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1. Preface 
The phrase "T cell activation" usually refers to the immune activation of mature T 
lymphocytes in peripheral blood, lymphatics, or tissue. During immune activation T cells 
undergo a sequence of genetic and phenotypic changes, which results ultimately in T cell 
clonal expansion and in the induction of T cell effector function. The physiological 
stimulus that activates T cells is foreign antigen in association with the major 
histocompatibility molecules, presented to the T cell by another cell. Multiple receptors on 
the surface of the T cell mediate the interaction between the T cell and the antigen-
presenting cell. The antigen specificity is dictated by the T cell antigen receptor (TCR). 
During the past 10 years an enormous progress has been made in the 
understanding the mechanisms of TCR-mediated signal transduction. The catalytic event 
of this progress was the recognition that components of antigen and IgFc receptors 
contain a common sequence motif in their cytoplasmic tails. The motif, described first in 
1989 by Michael Reth has come to be known as the immunoreceptor tyrosine-based 
activation motif (ITAM). Its predominant occurrence in the signalling subunits 
immunoreceptor complexes and its location in the cytoplasmic tails suggested a role in 
interaction with cytoplasmic signaling effectors. Recently the ITAMs have been found in 
invertbrate signal transducing proteins, proving the conservative nature of signal 
transduction pathways. To date, the mechanism of ITAM-mediated signal transduction has 
been revealed. Following TCR triggering the tyrosine residues within ITAMs become 
rapidly phosphorylated. Tyrosine-phosphorylated ITAMs recruits intracellular signalling 
proteins via their src-homology 2 (SH2) domains and a cascade of biochemical events is 
initiated by sequential molecular interactions. 
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2. Introduction 
2.1. Structure of T Cell Antigen Receptor 
T cells recognize antigens by means of membrane-bound T-cell receptor complex 
(TCR). Two distinct forms of TCR complexes- TCR a(3 and TCR y5- define the a p and 
y8 T-cell lineages. The TCR complex consists of two structurally and functionally distinct 
modules: an antigen binding module which consits of the clonotypic a P or y5 
heterodimers and a signalling module composed of the CD3 y, 8, s and CJr\ invariant 
chains (1,2). 
2.1.1. The antigen binding module 
The antigen binding module consists of the clonotypic TCR aP or TCR y5 
disulphide-bound heterodimers (reviewed in 1). In the adult, most of the T lymphocytes 
express TCR heterodimers containing the a and P chains, whereas a minor population 
expresses an alternative TCR isoform consisting of y and 5 chains (1, 2). 
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The TCR a, P and y, 8 chains are type I transmembrane glycoproteins. Each 
chain comprise an amino-terminal, clonally variable (V) region, an a-helicoidal 
transmembrane region, and a carboxi-terminal (C) constant region (Fig. 1) (1,2). Three 
peptide loops homologous to immunoglobulin (Ig) complementarity-determining regions 
(CDRs) are found at the membrane distal end of the V regions, where they collectively 
form the binding site for antigenic peptides that are bound to products of the major 
histocompatibility complex (MHC). The Va and VP CDR 3 are structurally hypervariable 
whereas the diversity of the Va and VP CDR1 and CDR2 loops is rather limited. The C 
regions consist of four functional domains. The most amino-terminal domain contains two 
cysteine residues spaced appropriately for the formation of an intrachain disulphide 
bonded loop, which probably folds into a tertiary structure similar to an Ig constant region 
domain. A short hinge region comprises the second part of the C region and contains a 
cysteine residue most likely involved in the disulphide linkage of the two chains. The third 
part of the C region is the transmembrane domain, composed of predominantly 
hydrophobic aminoacid residues. An unusual feature of these transmembrane portions is 
the presence of a lysine residue (P and y chains) or a lysine and an arginine residues (a and 
5 chains) positively charged side chains which may be crucial for the noncovalent 
association with the negatively charged residues found in the transmembrane portions of 
the CD3/¿¡ polypeptides (Fig. 1). The carboxy terminal part of the C region forms a short 
(5-12 aminoacids) cytoplasmic tail, that is unable to couple the extracellular part to the 
intracellular signalling machinery. 
2.1.2. Signalling module components 
The components of the TCR signalling module are the CD3 and CJr\ invariant 
polypeptides (1-4, 7). The CD3 y, 8 and e chains exist as noncovalently associated y8 and 
eS heterodimers in the TCR complex (Fig. 1). In contrast the chain is expressed as a 
disulphide bound homodimer in 90% of TCRs or as a (¡n heterodimer in the remaining 
10% of TCRs (1,2). 
Unlike the antigen binding subunits, these polypeptides have longer cytoplasmic 
tails (44 - 155 aminoacids) that are responsible for coupling the antigen-binding TCR afi 
or yS heterodimers to intracellular signalling pathways. Each CD3 or C/r\ subunit contains 







sequences, referred to as the immunoreceptor tyrosine-based activation motifs (ITAMs), 
are defined as two exactly spaced YxxL sequences (YrxL/Ix^YrxL/I; in a single-letter 
amino acid code, where x denotes nonconserved residues) (3,4). The motif is found the 
signalling components of other immunoreceptor complexes such as the B-cell receptor 
(BCR) subunits Iga and Igß, and the Fc receptors (FcRs) (Fig.2.2) (5). 
Recently the ITAMs have been found in 
invertebrate proteins such as the A74 protein, 
a transmembrane signal transducing molecule 
involved in the cellular immune defense 
reactions in Halocynthia roretzi,, suggesting 
the conservative nature of signal transduction 
pathways throught the evolution (6). 
Furthermore, the motif is also found in certain 
viral proteins, including bovine leukemia virus BCR 
gp30, Epstein-Barr virus proteins LMP2A 
and EBNA2 and simian immunodeficiency 
virus protein Nef, suggesting that these Fig. 2.2. ITAMs in the mammalian antigen and Fc 
. . . receptors. The consensus residues are indicated by boxes, 
molecules could provide a signaling function in 
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a) The CD3subunits 
The CD3 complex comprises three distinct members that are the 25-28 
kDa glycosylated y chain, a 20 kDa glycosylated 5 chain, and a 20 kDa nonglycosylated s 
chain (1) (Fig. 2.1.). The invariable y, 8, and s genes are members of the immunoglobulin 
supergene family. They are highly homologous to each other and are found in a cluster on 
human chromosome 11 (1, 2, 7). The y, 8 and s chain proteins each include an N-terminal 
extracellular region with a single Ig-like domain, a short connecting sequence, a 
transmembrane segment, and a cytoplasmic tail (Fig. 2.1.). 
There is no variability or polymorphism identified in the extracellular domains of 
the CD3 proteins or their genes, and therefore it is not likely that these proteins contribute 
to antigen recognition (2). The transmembrane segments of all three chains contain a 
negatively charged aspartic acid residue (Fig. 2.1.). This unusual feature may be important 
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for the physical association or functional interactions of the CD3 proteins with the TCR a 
and P chains, since the latter polypeptides each contain a positively charged lysine residue 
in their transmembrane domains (2, 7). The cytoplasmic domains of the CD3 subunits 
range from 44 to 81 aminoacid residues and each contains one copy of an IT AM motif (2, 
3). 
b) The C chain 
The C chain is a 16 kDa nonglycosylated polypeptide that belongs to a family of 
structurally and functionally related molecules that includes C> r| (an alternatively spliced 
form of C) and FceRIy (2, 7). The C gene is found on the human chromosome 1, 
separately from other TCR and CD3 genes. The C and r\ chains are structurally different 
from the CD3 proteins (2). Unlike the other CD3 proteins, the C gene products do not 
belong to the IgG superfamily. They have a very short extracellular part (nine aminoacids) 
and long cytoplasmic tails (113 aminoacids and 1SS aminoacids for C, and r\ respectively) 
(2,7). The transmembrane domains contain a negatively charged aspartic residue (similar 
to the CD3 chains). Both C and rj chains have multiple ITAMs in their cytoplasmic tails 
(two for ri and three for C, chain ). In addition, the C chain contains a GTP/GDP binding 
site that may also have a role in signal transduction (9). 
2.1.3 . Composition and membrane organization of the TCR 
Currently, it is accepted that the T cell receptor is composed of at least six 
different polypeptide chains consisting of the clonotypic heterodimer (a|3 or y8), the 
noncovalently associated CD3 chains (CD3y, 5, e) and the CC o r Cn dimers. The exact 
number of subunits setting up one TCR molecule is still not well established, however, 
several models have been proposed for the composition of the TCR. 
a) the heptameric model (10) predicts the presence of a TCRaP hetrodimer 
associated with a CD3y5e complex and a CC o r Cn dimer. 
b) the octameric model (TCRap/CD3ye8e/CQ has replaced the heptameric model 
when it was demonstrated that two CD3e chains are present in the TCR complex ( 11-13). 
The model predicts that the ye dimer is associated with the P chain and the §e dimer is 
associated with the a chain. This model cannot explain how the C2 dimer is associated with 
the TCR. 
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c) The decameric model (14) has been recently proposed for TCR based on the 
finding that the variable domain of the a chain crystallized as a dimer of two 
Va homodimers (14, 15). The decameric model predicts that the TCR/CD3/£ complex is 
bivalent. The bivalent decamer comprises two TCRaP heterodimers with a net 
transmembrane charge (TmC) of +6, a single CD3ye module (TmC= -2), a single CD38e 
module (TmC= -2), and a single ¿¡C or £n dimer (TmC= -2). Thus organized, the complex 
has a thermodinamically favourable neutral TmC which is probably a requirement for the 
stabilization of the TCR complex in the hydrophobic transmembrane region. 
2.2. T Cell Antigen Receptor Function 
2.2.1. Antigen recognition hv TCRs 
Most of the a(3 T cells recognize antigens as small peptide fragments bound to 
major histocompatibility complex (MHC) molecules on the surface of antigen presenting 
cells (APCs) (16-22). Recently, it has been shown that aP T cells can also recognize non-
protein antigens such as lipids and lipoglycans of the bacterial cell wall, presented in 
association with the MHC protein CD1 (22- 24). In contrast, y8 T cells appear to 
recognize both peptidic and non-peptidic antigens in a TCR-dependent but MHC-
independent manner (25, 26). 
2.2.1.1. Antigen recognition by a/7-TCR 
The primary function of aP T cells is to recognize the presence of pathogens 
within the body and to activate their disposal either directly or by recruiting other immune 
cells (16). Most of the aP T cells recognize antigens as small peptide fragments bound to 
major hisocompatibility complex (MHC) molecules on the surface of antigen presenting 
cells (APCs). There are two distinct classes of MHC molecules (16). Class I molecules are 
expressed on almost all nucleated cells and present antigens derived from cytoplasmic 
peptides like cytoplasmic and nuclear proteins of viral origin or proteins from 
intracytopiasmic bacteria and class II molecules are expressed on professional APCs and 
that present peptide antigens derived from extracellular sources (16). Class I molecules 
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present antigen to cytolytic CD8+ T cells that become activated and directly eliminate the 
presenting cell via apoptosis induction, while the recognition of complexes of antigenic 
peptides with MHC class II molecules results in the activation of both the APC and of 
CD4+ T helper cells. Activation of T helper secrete cytokines that stimulate the 
macrophages to kill phagocytosed micro-organisms, or activate B cells and drive their 
differentiation into antibody secreting cells, or help cytotoxic T cells to kill target cells 
(16). 
The way how aP TCR recognizes its peptide/MHC ligand was postulated from the 
analysis of the CDRs of the antigen binding subunits (17-21). The CDR1 and CDR2 loops 
are relatively conserved and are restricted in size and conformation suggesting a 
predominant role in binding to the MHC molecules. In contrast, CDR3 loops are 
hypervariable and have been predicted to be involved in peptide recognition. Mutagenesis 
studies supported the previous predictions that CDR 1 and 2 of both a and P chains are 
involved in binding to the MHC molecule whereas CDRs 3 are critical for the recognition 
of the peptide. The precise orientation between a MHC- peptide complex and the TCR has 
been recently established when the high-resolution crystal strucure of a human TCR-
MHC-peptide complex was reported (reviewed in 20). In this structure, the CDR1 and 
CDR3 of both a and P chains interact with the peptide. All three CDRs of the a chain and 
CDR3 of the P chain interact with the MHC molecule. 
The aP T cells can recognize also nonprotein antigens such as lipids and 
lipoglycans of the bacterial cell wall, presented in association with other MHC gene 
products - the CD1 molecules (22-24). Such ap T cells have either double negative, CD4" 
CD8" or single positive, CD4~ CD8+ phenotype in humans. 
2.2.1.2. Antigen recognition by yS-TCR 
The y§ T cells apparently share a propensity with macrophages to recognize 
nonpeptidic molecules of the kind most commonly associated with micoorganisms, viruses 
and stressed cells but not by normal cells (25, 26). With few exceptions, recognition of 
these antigens by y8 T cells involves the TCR but does not require APCs to express MHC 
gene products or to have a functional antigen processing machinery (26). Functionally, y§ 
T cells appear to posses intrinsic cytolytic activity against transformed cells of various 
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origins and to provide signals that can significantly influence the quality of innate as well 
as aquired immune reponses (26). In other instances, y§ T cells may participate in non-
immune functions aimed at preserving or re-establishing tissue integrity (26). 
2.2 .2 . Mechanism of transition from antigen binding and 
recognition to cell activation 
The sensitivity of antigen-specific response by T cells is remarkable. However, in 
vitro the TCR aP interaction with MHC-antigenic peptide complex is characterized by 
low affinity and high off rate (27-29). To explain this high-sensitivity-low-affinity paradox 
several models for T cell activation have been proposed. 
The first model predicts that following the engagement, TCR molecules oligomerize at 
the plane of the cell-cell contact (28-31). Receptor clustering could favour sustained 
signalling in three ways (32): 
1) by increasing the likelihood of contacts between the TCR and the MHC-bound ligand; 
the increased concentration of TCR molecules in a high-density zone would allow low-
affinity receptors to initiate and maintain signals; 
2) by increasing the concentration of cytosolic signalling molecules and second 
messengers at regionally organized focal points in the proximity of TCRs; 
3) by excluding negative regulatory molecules such as phosphatases from the zone of 
antigen receptor signalling. 
The degree of assembly of the signalling complex determines the extent and qualitative 
nature of the transduced signal (33). 
The second model predicts that under physiological conditions T cells are triggered 
by sequential monovalent engagement of many TCRs by a small number of peptide-MHC 
complexes (34-36). This allows accumulation of TCR-activated signalling molecules over 
time and cell activation. The model is sustained by time-lapsed microscopy which reveals 
that the T-cell -APC interaction is a dynamic process, with the T cells "crawling" on the 
surface of the APC (37). 
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2.2.3. Signal transduction via T cell receptor 
Following antigen recognition, T cell receptor signalling is the next decisive 
factor in the initiation of the specific immune response. The capacity of the TCR to 
transduce signals across the membrane is mediated by the ITAM sequences that are 
located in cytoplasmic regions of the TCR invariant chains (3, 7, 38- 40). 
The initial membrane proximal event triggered by the TCR is activation of 
protein tyrosine kinases (PTKs) with the resultant phosphorylation of ITAMs and other 
cellular proteins (41, 42). The function of the PTKs pathway is obligatory for the T cell 
activation as proved by the inhibitory effects of tyrosine kinase inhibitors on TCR 
induced IL-2 production (43). This biochemical response couples the TCR to a divergent 
array of signal trasduction molecules including Src, Syk and Tec family tyrosine kinases 
2+ 
(41, 44), enzymes that regulate lipid metabolism and Ca mobilization (45), 
serine/threonine kinases (45), GTP binding proteins (46), and adaptor molecules (47). 
Several transcription factors are subsequently activated which ultimately results in 
modulation of T cell surface phenotype, the regulation of the secretion of critical 
cytokines and clonal expansion (48). 
2.2.3.1. Activation of Src family PTKs 
The earliest biochemical response elicited by the TCR is activation of Src family 
nonreceptor PTKs. The Src family of PTKs consists of nine closely related members, 
each of which contains an ami no-terminal myristilation site (Src homology 4 domain, 
SH4), an amino-terminal segment specific to the particular member, a proline rich 
domain -binding region (SH3), a phosphotyrosine-binding domain (SH2), a catalytic 
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Fig. 2.3. Schematic structure of Src- family tyrosine kinases. Myr: myristilation; SH: Src homology 
domain; Y: tyrosine residue (copiedfrom ref. 54). 
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Two src tyrosine kinases have been implicated in T-cell activation: p59^n which 
lck 
associates with the cytoplasmic domain of the £ chain of the TCR, and p56 which 
couples to the CD4 and CD8 molecules and therefore is in close proximity to the TCR 
during antigen recognition (50-53). 
Src kinases have two principal regulatory tyrosine phosphorylation sites: one is 
located within the SHI domain and the other is located in the carboxy terminal region 
(Fig.2.3.). The crystal structure of active Lck indicates that phosphorylation within the 
kinase domain enhances kinase activity by correctly positioning a loop within the 
catalytic domain for optimum phosphotransferase activity (Fig.2.4.) (54-56). 
Phosphorylation of the C-terminal inhibitory site inhibits kinase activity because this 
phosphotyrosine residue forms an intramolecular association with the SH2 domain. This 
induces a conformation with low catalytic activity, stabilized by an interaction between 
the SH3 domain with a segment within the hinge region that joins the kinase domain and 
the SH2 domain (57). 
Fig. 2.4. Mechanisms for Src-family kinases activation. In resting T cells, CD45 opposes the inhibitory 
kinase Csk, but simultaneously dephosphorylates the site within the kinase domain, with the net effect of 
keeping the Src kinases inactive. Activation of Src kinases can be achieved by: (1) dephosphorylation of the 
inhibitory site (site 2) and phosphorylation of the site within the kinase domain (site 1); or (2) interaction of 
the kinase with high-affinity binding sites for the SH2 and SH3 domains in other proteins (copied from ref. 
54). 
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Phosphorylation of the tyrosine within the kinase domain is achieved by intermolecular 
transphosphorylation (54), while the C-terminal phosphorylation is achieved by the C-
terminal Src kinase (Csk) (Fig. 2.4.). This kinase, has a similar structure to Src-family 
members, but it is devoid of sites for lipid modification and tyrosine phosphorylation, 
and therefore, it is constitutively active (54). 
Significantly, the intramolecular interaction between the inhibitory tyrosine 
phosphate and the SH2 domain of Src kinases is of low affinity. Furthermore, 
investigations on the mechanism of activation of Hck kinase revealed that the SH3 -
catalytic domain interaction may be more important than the SH2-tail interaction in 
maintaining the repressed form, since high-affinity ligands for the SH3 domain are more 
potent than SH2 ligands in activating kinase (57, 58). Thus, a possible mechanism for 
activation of Src-family kinases is the binding of the SH2 or SH3, or both, domains to 
high affinity sites in other molecules. 
Another model for activation of Src-family kinases involves the protein tyrosine 
phosphatase CD45 (reviewed in ref. 59). According to this model, in resting T 
lymphocytes CD45 is constitutively active and dephosphorylates both the 
(a) Steady state 
Integrin 
CD45 — I Lyn/Lck 
Dephosphorylation of 









Exclusion of CD45 
from receptor complex 
Lck 
Transphosphorylation 
and activation of kinase 
Fig. 2.5. Model for TCR activation, (a) In resting cells (steady state), various molecules are distributed 
randomly in the cell membrane. Src-familly kinases are under continual regulation by two active enzymes, CD45 
and Csk. CD45 simultaneously dephosphorylates the inhibitory site of Lck and/or Fyn (on the left of the 
molecule) and the autophosphorylation site (on the right of the molecule) with the net effect of keeping Src 
kinases inactive, (b) Antigen receptor engagement leads to the formation of glycosphingolipid-enriched domain 
(DIG). This results in the selective recruitement of Src kinases to the TCR and in the exclusion of CD45. 
Because the inhibitory site within Src kinases is already dephosphorylated, transphosphorylation occurs leading 
to kinase activation (copiedfrom ref. 54). 
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autophosphorylation and negative regulatory tyrosine residues of the Src family PTKs 
keeping therefore the Src kinases inactive (60) (Fig.2.5. a). After TCR stimulation, Src-
family kinases, CD4, CD8 and LAT are recruited at the apposition of the membranes. 
CD45 is sequestered from the developing signalling complex and the transphosphorylation 
and kinase activation is allowed (Fig.2.5. b) (54). 
The importance of Src family kinases Lck and Fyn in TCR signalling was revealed 
by studies using mutant T cell lines, or by gene targeting in mice (reviewed in ref. 53). 
Following activation of Src kinases, the CD3 and C, chain ITAMs are rapidly tyrosine 
phosphorylated and become docking sites for SH2-domain containing effector and adaptor 
molecules involved in TCR signalling cascade. Studies of the JCaM 1.6 -a mutant Jurkat 
leukaemic T cell line deficient in Lck- showed a dramatic decrease in TCR-induced 
phosphorylation of C, chain and of ZAP-70, and led to the proposal that TCR signalling is 
initiated by Lck activation (53). Accordingly, in Lck-deficient mice the basal 
phosphorylation of C, and the TCR-induced phosphorylations of CD3 8 and ZAP-70 were 
greatly reduced, though not completely abrogated suggesting that in the absence of Lck 
another kinase may partially take over its function (53). The obvious candidate for this is 
the Fyn kinase which, like Lck is activated upon TCR stimulation. The idea that Fyn and 
Lck may have overlapping functions in TCR signalling comes from analysis of Lck^Tyn"'" 
double mutants. In Lck'/_ mice, thymocyte development is partially blocked at the CD4~ 
CD8" double negative to CD4+CD8+ double positive transition. In contrast, in Lck^Tyn"'" 
mice development is completely arrested at the double negative stage, demonstrating that 
Fyn can partially substitute for Lck (53). 
Recent data demonstrates a functional role for Lck beyond IT AM phosphorylation 
and activation of ZAP-70 and Syk PTKs (61, 62). The expression of constitutively active 
Syk family PTKs in the p561ck-deficient JCaM 1.6 cells failed to rescue signalling events 
downstream of tyrosine phosphorylation, demonstrating a functional role for Lck beyond 
the activation of ZAP and Syk (61). Furthermore, co-expression of Syk and Lck, or TCR 
activation (which leads to Lck activation) in cells expressing Syk, results in enhanced 
phosphorylation of She, suggesting a synergism between the two kinases (62). 
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2.2.3.2. C - I T A A A S phosphorylation and their role in the formation of 
the signalling complex 
Ick 
The phosphorylation of the CD3 and C ITAMs is mediated by activated p56 and 
p59^" (41, 42, 45, 63). 
A specific order of C, chain 
phosphorylation has recently been 
described using site-specific anti-
phosphotyrosine antibodies (63). 
Phosphorylation of the membrane-
proximal ITAM precedes phospho-
rylation of the other two ITAMs (63). 
The differently tyrosine phosphorylated 
chains migrates forms in SDS-PAGE 
as several distinct molecular species 
with molecular mass of 18, 21 and 23 
kDa, which represent different phospho-
rylation of the six tyrosine residues in 
the three ITAMs (referred to as Al , A2, 
Bl , B2, CI and C2) (63, 64). The pp21 
phosphorylation is due to A2, Bl and C2 
phosphorylation, while pp23 is represented mainly by the fully phosphorylated form but 
may also contain incompletely phosphorylated C, species (63). In resting 
T cells the nonphosphorylated 16 kDa C chain (pi6) and the partially phosphorylated 
pp21 forms are found (64). Upon TCR stimulation the phosphorylation of p i6 and pp21 
rapidly increases and multiple phospho-species of £ with molecular masses of 18, 21 and 
23-kD appear (63, 64). The ratio of pp21 and pp23 can be altered after stimulation of T 
cells with suboptimal ligands, suggesting a discriminatory role of C, phosphorylation in T-
cell activation (63, 65-67). 
The mechanism that conducts the generation of various phosphorylated forms in 
vivo has not been established. Once phosphorylated, ITAMs act as high affinity docking 
sites for the SH2 domains found in certain intracellular proteins with enzyme activity 
Fig.2.6. Structure of SH2-domain containg adaptor and 
effector molecules expressed in T cells. 
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(effector molecules) and in proteins that posses no intrinsic enzymatic function, but 
mediate protein-protein interactions (adaptor molecules), coupling therefore TCR to the 
intracellular signal transduction pathways (68-79) (fig.2.6.) 
2.2.3.3. Specificity and multiplicity of ¿TTAMs 
The requirement for multiple ITAMs within the C, chain may be explained by two 
hypothesis: 
a) individual ITAMs may function as docking regions for distinct effector 
molecules in order to activate distinct signalling pathways (the 'specificity 
model') 
b) the presence of multiple ITAMs may provide a mechanism for signal 
amplification, with different activation thresholds required for distinct functions 
(the 'threshold model'). 
There are experimental evidences supporting both alternatives. 
The hypotesis that ITAMs are involved in signal amplification (the 'threshold 
model') is supported by experimental data which prove that: 
1) In Jurkat T cells the stimulation of chimeric receptor complexes containing one, 
two or three C, ITAM motifs resulted in the induction of identical patterns of 
tyrosine-phosphorylated proteins. Furthermore, enhanced but not qualitatively 
distinct responses were seen when the chimera contained multiple ITAMs (3); 
2) Expression of truncated C, chain lacking all ITAMs or of £ chain containing only 
the or (¡3 ITAM in ¿¡-/- knock-out mice reconstitutes normal thymic 
development and activation of TCR (80); 
3) Analysis of C deficient mice that had been reconstituted with either full lenght or 
single ITAM containing C, subunits revealed that similar signalling events occur 
after TCR ligation regardless the number of ¿¡-ITAMs present in the TCR complex 
(81); 
4) The induction of cytoskeletal rearrangements by TCR can be mediated by any of 
the C or CD3e ITAMs (82). 
The assumption that the presence of three ITAMs in the C, chain is required for the 
formation of qualitatively distinct intracellular signals ('the specificity model') is supported 
by the following experimental data: 
17 
1) TCR agonists and antagonists initiate different patterns of C, chain 
phosphorylation, resulting either in T cell activation or anergy (63, 65-67); 
2) The three ITAMs of the TCR C chain differ in their ability to associate with 
intracellular SH2 domain containing proteins in vitro (68). Moreover, the same 
IT AM may interact with different proteins when it is found in a mono- or bi-
phosphorylated form (69-75) (Tab.2.1); 
Table 2.1. Qualitative and quantitative differences in the ability of differently phosphorylated 
£-ITAM peptides to interact with T-cell adaptor and signaling proteins. The relative intensity of 
the interaction is indicated with "+". Empty cells indicate that no data concerning the interaction 
were available. The references are indicated in superscript. 
Target 
protein 
ITAM1 ITAM2 ITAM3 
Cipyy Ciypy i i p y p y C2ypy C2pypy C3pyy C3ypy C3pypy 
p561ck ++73 +73 ++++73 ++73 ++73 
p59fyn 69 ++69 +/.68-69 ++68 _68 
ZAP-70 +69. 73, 103 69. 73, 103 ! ! | 69, 73. 130. 132 +69. 73 +/-73 1 1 ,73. 132 -r73 +73 1 | 73. 132 
Syk +++132 +++'32 +++166, 132 
PI3K 
(p85) 
1 | | 168.71, 131 _l 1^68, 71, 131 +67 +68, 70.71.131 
She +73 ++73, 130 +++7U30 +73 ++73 71 ++73 ++71'73 +71 
Grb-2 +7' +++7' _71 
RasGAP +++68.7> ! ! 68. 71 ++7' _l_68 71 
SHP2 +131 
3) There is a heterogeneity in the amino acids adjacent to the phosphotyrosines in 
the various C, ITAMs. It has been shown that these aminoacids determine the 
specificity of binding of SH2 domains, suggesting that individual C, ITAMs 
could couple to distinct SH2 domain signalling proteins (83, 84); 
4) Different C, ITAMs have distinct abilities to promote apoptosis. Analysis of 
apoptosis induced by single C, ITAM Tac chimeras in T cells revealed that the 
amino-terminal ¿¡ITAM stimulated greater apoptosis than the carboxy-terminal 
¿¡IT AM, while the central ¿¡ITAM was unable to trigger apoptosis (85); 
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5) Detergent-soluble and cytoskeleton associated TCRs contain differently 
phosphorylated C, molecules (86). 
The T cell response to extracellular signals may depend on the composition of the 
developing signalling complex on the cytoplasmic tail of the TCR C chain, which is 
determined by the phosphorylation pattern of the C, ITAMs. It is also possible that the 
'specificity model' and the 'threshold model' are not mutually exclusive, and may be 
differentially utilised depending on specific conditions of T cell activation. 
2.2.3.4. Activation of ZAP-70 and Syk PTKs 
Tyrosine phosphorylation of the ITAMs in £ chain and their sequential SH2-
mediated interaction with ZAP-70 tyrosine kinase are essential for the initiation of TCR-
mediated signal transduction (65-67, 87, 88). Patients lacking functional ZAP protein 
display severe defects in TCR signaling as well as an absence of peripheral T cells (87). 
Similar defects in the Syk gene have not been reported. Furthermore, thymic development 
of lymphocytes in ZAP-70 mice is completely blocked at the double-positive stage 
(reviewed in 53). 
The binding of ZAP-70/Syk PTKs with the doubly phosphorylated ITAMs (dp-
ITAMs) results in the activation of these PTKs (41, 42, 88). The activated kinases then 
phosphorylates substrates such as Cbl, SLP-76 76 (SH2 domain-containing leukocyte 
phosphoprotein of 76 kDa), Vav, PLCy (phospholipase Cy), and LAT (linker for 
activation of T cells) (88-92, 94). Further signal transduction events lead to the activation 
of both Ca/calcineurin- and Ras-mediated signaling pathways (see section 2.2.3.5.). 
Analysis of the recently identified PI 16 cell line (a variant of Jurkat T cell line) which is 
deficient in both ZAP-70 and Syk has confirmed two crucial roles for ZAP70/Syk family 
PTKs: first in the phosphorylation of PLCy 1, SLP-76 and LAT; second in TCR-induced 
Ca2+ mobilization, activation of the transcription factor NFAT (nuclear factor of activated 
T cells) and IL-2 production (96). 
Syk and ZAP-70 are both composed of two tandem amino-terminal SH2 domains 
separated by an interdomain (interdomain A), followed by an extended interdomain region 
(interdomain B), the kinase domain and by a short C-terminal tail (reviewed in ref. 88) 
(Fig. 2.7.). The two kinases share greater than 50% sequence identity, and several 
conserved tyrosine residues that are important both for the regulation of the enzyme 
88) (Fig. 2.7.). The two kinases share greater than 50% sequence identity, and several 
conserved tyrosine residues that are important both for the regulation of the enzyme 
activity and for the association of these kinases with other signalling molecules (Fig 2.7.) 
(88). Most of these conserved tyrosine residues are located in interdomain B. The Y315 
and Y319 in ZAP which corresponds to Y348 and Y352 in Syk are implicated in positive 
regulation of the kinase activity (88). Phosphorylation of these tyrosine residues is also 
important for the association of ZAP and Syk with the SH2 domain of Vav (Y315/348) 
and with the SH2 domain of PLCyl and/or p561ck (Y319/352). In contrast, Y292 in ZAP 
and Y323 in Syk are negative regulatory sites. A balance between negative regulation via 
Y292/Y323 and positive regulation via Y315/348 and Y319/352 may therefore control 
the activity of ZAP and Syk (88). 
The kinase domains of ZAP and Syk contain also conserved regulatory sites that 
are found within the activation loop of the kinase domain, Y492/493 in ZAP and 
Y525/526 in Syk. In ZAP-70, Y492 and Y493 are sites for tyrosine phosphorylation by 
Lck (88). Y492 has been shown to be a negative regulatory site, whereas Y493 is a 
positive regulatory site for ZAP-70 kinase activity. In Syk, Y525 and Y526 are sites for 
autophosphorylation and both act as 
positive regulators of Syk activity (88). 
The SH2 domains of Syk and 
ZAP-70 have 56% sequence homology. 
The most distinctive aspect of the SH2 
domains present in ZAP-70 is that they 
bind to their targets in the TCR/CD3 
complex in a co-operative manner (88, 
95). The molecular basis of this co-
operativity has been established with the Fig. 2.7. Structure of Syk-family PTKs. The Syk family 
crys ta l iza t ion of its t a n d e m SH2 kinases are composed of two SH2 domains (SH2-N and SH2-C) 
with an intervening interdomain A (IA), an extended interdomain 
d o m a i n s c o m p l e x e d wi th a B (IB) and kinase domain (Kinase). Conserved tyrosine 
phosphorylation sites are indicated. (Copied from ref. 88). 
phosphorylated ITAM peptide from the 
TCR C chain (95). The N-terminal SH2 
domain appears to be incomplete and requires amino acid contributions from the C-
terminal SH2 domain to help complete the phosphotyrosine binding (PTB) pocket. In 
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IT AM peptide revealed that the two SH2 domains of Syk form two independent binding 
pockets for the phosphotyrosines (96). 
Despite the structural similarities there is evidence indicating that Syk and ZAP-70 
are differentially regulated both in terms of expression and activity (88). ZAP-70 is 
expresed in a very restricted manner, present only in T cells and natural killer cells. Syk, 
however, has a broader pattern of hematopoietic expression, including T and B cells, as 
well as macrophages, monocytes, mast cells, and platelets (88). However, while ZAP-70 is 
expressed in all T cells, Syk is present only in thymocytes and intraepithelial y§ T 
lymphocytes and in naive but not in proliferating mature <x(3 T cells (93). 
Both SH2 domains of ZAP and Syk have to be occupied with phosphotyrosine 
residues for full activation of the enzymes. Although both kinases bind dp-ITAMs with 
similar affinities only Syk kinase activity is directly enhanced by phospho-ITAM binding 
(41, 70, 88). Phospho-ITAM binding results in an upregulation of Syk activity by 
facilitating the cross-phosphorylation of two Syk molecules (41, 88). In contrast, binding 
of ZAP-70 to doubly phosphorylated ITAMs is required but not sufficent for enhancing 
the catalytic activity of ZAP. Activation of ZAP requires phosphorylation of Tyr493 by 
Src PTKs. Phosphorylation of this site can be mediated by Src PTKs, but not by ZAP-70 
autophosphorylation (41, 88). 
Furthermore, like Src family kinases, Syk but not ZAP-70 has the capacity to 
directly phosphorylate a (¡-derived peptide in vitro (98, 99). Also, Syk but not ZAP-70, 
can reconstitute signalling in mutant Jurkat T cell deficient in either p56/c* or CD45 (97). 
Studies using the ZAP/Syk negative Jurkat mutant PI 16 transfected with either Syk or 
ZAP revealed that Syk-expressing cells were partially activated even in the absence of 
TCR ligands (98, 99) indicating that the activation threshold for Syk is significantly lower 
than that of ZAP-70. 
2.2.3.5. Signal transmission from PTKs to the nucleus 
The role of ZAP and Syk is to couple antigen receptors to essential signalling 
pathways- one mediated by the GTPases p21ras and the other mediated by 
2+ 
Ca /calcineurin (45, 46). Recent data suggest that connection of TCR to the Ras pathway 
is mediated by a series of adaptor molecules among which are: She, LAT, SLP-76 and 
Grb2 (growth factor receptor binding protein 2) (47, 94). LAT is also essential for linking 
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TCR to PLC pathway (47, 94). Some of these proteins - i.e. LAT, SLP-76, and PLCy-
are ZAP/Syk substrates (89, 92, 94). Another substrate of Syk family kinases- the guanine 
nucleotide exchange factor Vav- ensures the link between TCR and the cytoskeleton (47, 
90). 
2.2.3.5.1. Regulation of inositol lipid metabolism, Ca2Vcalcineurin and 
PKC pathway byTCR 
The first well characterized PTK-controlled TCR signalling pathway is mediated 
by PLCyl (45, 48). PLC yl hydolyzes inositol phospholipids and thereby generates 
inositol polyphosphates which regulate intracellular calcium levels and diacylglycerols 
which activates the serine/threonine kinase, protein kinase C (PKC) (45). PLC y is tyrosine 
phosphorylated by Syk family kinases in TCR-activated cells, a process that is important 
for its activation. The TCR also induces the formation of a protein complex between the 
SH2 domains of PLCy and LAT. Since LAT is a transmembrane protein, the interaction 
between LAT and PLCy may be important to recruite PLCy to its substrates located in the 
plasma membrane (46). The function of calcium and PKC signals in TCR signalling has 
been explored mainly in the context of TCR regulation of the production of cytokines. For 
example, the IL-2 gene induction requires the co-ordinate action of multiple transcription 
factors that include NFAT, AP-1, NFkB and Oct-1 (45) whose activity is controlled by 
PLC pathway (Fig.2.8.) (46). Pharmacological agents, ionomycine and phorbolesters, that 
directly induce the Ca2+ elevation and PKC activation, respectively, stimulates T 
lymphocytes to proliferate and to produce IL-2 (45, 100). 
2.2.3.5.2. Ras GTP-ase pathway 
The level of active p21ras GTP complex is determined by a balance of the rate of 
hydrolysis of bound GTP and the exchange rate of bound GDP for cytosolic GTP (45, 
47). The GTPase activity of Ras in mammalians is controlled by Ras GTP-ase activating 
proteins (GAP) pl20-GAP and by proteins that regulate guanine nucleotide exchange on 
Ras, (guanine nucleotide exchange factors, GEFs). Signals via TCR are able to regulate 
the activation of the guanine nucleotide binding proteins p21ras both via inhibition of 
GAPs and activation of GEFs (45). The mechanism that allows TCR to inhibit GAP 
proteins is unclear. The regulation of RasGEFs by TCR involves an adaptor protein- Grb 2 
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GAPs and activation of GEFs (45). The mechanism that allows TCR to inhibit GAP 
proteins is unclear. The regulation of RasGEFs by TCR involves an adaptor protein- Grb 
2 (47). Grb2 is a small protein comprising a central SH2 domain flanked by two SH3 
domains (Fig. 2.6.). The SH2 domain of Grb2 binds to tyrosine phosphorylated molecules 
from the TCR complex and its SH3 domains bind to the proline-rich domain of Sos (a 
GEF) bringing therefore Sos to the plasma membrane where it may facilitate Ras 
activation (45). Grb-2 is inducibly associated with Sos following TCR ligation (47). 
Grb2/Sos complex may be bound either directly to phosphorylated ITAMs or indirectly 
through interacting with other adaptors such as She, LAT and/or SLP-76 (47) (Fig. 2.8). 
T r a n s c r i p t i o n a l l y a c t i v e 
N F A T c o m p l e x 
Fig.2.8. Signal transmission from TCR to the nucleus. Engagement of cell-surface TCR complex 
initiates the activation of membrane proximal PTKs, which leads to tyrosine phosphorylation of LAT and 
couples the TCR to PLCy and Ras-regulated signaling pathways. Transcription factors of the NFAT 
ffamily regulate cytokine gene expression and are activated by signals emerging from Ras which act in 
synergy with calcium/calcineurin and PKC signals. DAG, diacylglycerol; NFATc, cytosolic NFAT; 
NFATn, nuclear NFAT; P2 diphosphate; • phosphorylated. (Copied from ref.46) 
The transmission of signals from Ras to the nucleus involves the regulation of the 
MAP kinases (mitogen activated kinases), ERK1 and ERK2 (reviewed in refs. 45, 47). 
The MAP kinases are activated by a serine/threonine kinase cascade involving a MAP 
kinase kinase (MAPKK) that phosphorylates and stimulates ERK1 and ERK2 directly. 
The activity of the MAPKK is itself controlled by phosphorylation, with MAP kinase 
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domain of Raf-1 can interact directly with GTP-Ras, and it has been suggested the role of 
Ras is to recruit Raf-1 to the plasma membrane where it is activated. Once activated, 
ERK2 may translocate to the nucleus where they can directly modulate transcriptional 
factors and gene expression. 
2.2.3.6. The role of cytoskeleton in TCR signalling 
T cell receptor activation is associated with changes in cell morphology that are a 
result of cytoskeleton rearrangement. These changes lead to the organization of focal 
actin-scaffolded signaling "highways" whose function is to sustain TCR signalling and co-
ordinate downstream signalling events such that complete activation is achieved and late 
events such as proliferation and cytokine secretion can occur (46, 101). The link between 
TCR and cytoskeleton is insured by Vav. Vav is a GEF with selectivity for Rho family 
GTPases, Rac 1, CDC42, and Rho A (reviewed in 46). The guanine exchange activity of 
Vav is directly regulated by tyrosine phophorylation. In activated T cells Vav is a substrate 
for Syk family kinases (91). In addition, a protein complex beetwen Vav and another Syk 
PTKs substrate, the adapter protein SLP-76, is formed in response to antigen stimulation 
in T cells (46, 47). The formation of this complex is proposed to regulate the cellular 
localization of Vav, thereby promoting its interactions with Rho GTPases and/or tyrosine 
kinases. The GTPases, Rac, CDC42, and Rho function as molecular switches in cells and 
orchestrate receptor-mediated responses such as cytoskeletal changes and DNA synthesis 
(46). Target molecules for Rac, CDC42, and Rho differ widely in their functions and 
include such molecules as phosphatidylinositol 4-phosphate 5-kinase (PIP5K), CDC-42-
associated Wiscott Aldrich syndrome protein (WASP), myosin light chain (MLC) 
phosphatase, and the p21 -activated kinase (PAK). PIP5K phosphorylates PEP, resulting in 
the production and local accumulation of phosphatidylinositol 4,5 biphosphate (PEP2) (46). 
High concentrations of PIP2 can promote local actin polymerization and anchoring of the 
actin cytoskeleton to the cell membrane and to the organization of focal actin-scaffolded 
signaling "highways" (46, 101). 
2.2.3.7. Signal termination 
In contrast to T-cell activation, the mechanism of negative regulation of T cells is 
largely undefined. Negative regulation takes place in two phases- one during the initial 
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triggering of T cells and the other during latter stages (reviewed in ref. 102). Negative 
regulation of the initial phase of T cell activation appears to be mediated by two distinct 
mechanisms: 
a) the active induction of the negative signals through stimulation of cell surface 
molecules such as cytotoxic T lymphocyte antigen 4 (CTLA-4) 
b) the induction of unresponsive/anergic or supressive status through various 
mechanisms including inhibitory cytokines as well as modulation of the TCR 
complex and signaling molecules by redox regulation (102). 
For the late phase of T cell responses, negative fedback is required. This involves 
induction of growth inhibition, cell cycle arrest and apoptosis which are mediated through 
various molecules including inhibitory cytokines and the Fas system. 
T cells from CTLA4-/- mice revealed hyperphosphorylation of various proteins 
including TCR C chain, and showed that TCR-associated kinases Lck, Fyn and ZAP-70 
were constitutively activated, suggesting that CTLA-4 interferes with the activation of 
these molecules (102). In normal cells CTLA-4 was found to associate with the SH2 
domain of SH2 domain containing PTPase 2 (SHP-2) via a phosphorylated tyrosine-
containing motif: Tyr-Val-Lys-Met suggesting that phosphorylation of CTLA-4 recruits 
SHP-2 and that the activated SHP-2 may dephosphorylate TCR-associated kinases and 
other substrates. 
Other PTPs have been suggested to play an important role in the negative 
regulation of TCR signalling such as SHP-1 and CD45. SHP-1 can act at multiple steps in 
TCR activation cascade by dephosphorylating TCR£, p56lck and ZAP-70 in vivo (103, 
104). CD45 has been shown to co-distribute with ZAP-70 in intact T cells, and ZAP-70 
was dephosphorylated by CD45 in vitro (105). 
The mechanism that controls the activity of these phosphatases is still unknown. 
2.2.3.8. CD45 structure and its role in TCR signaling 
The CD45 (also termed leukocyte common antigen-LCA, Ly5, B220 in B cells and 
T200 in T lymphocytes) is a family of transmembrane protein tyrosine phosphatases 
(PTPases) uniquely and abundantly expressed on nucleated hematopoietic cells. CD45 is 
encoded by a single gene located in a syntenic region found on chromosome 1 both in 
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(PTPases) uniquely and abundantly expressed on nucleated hematopoietic cells. CD45 is 
encoded by a single gene located in a syntenic region found on chromosome 1 both in 
humans and mice (106). It functions as a key regulatory element in TCR signalling by 









2.2.3.8. 1. Structure of CD45 
CD45 is a transmembrane protein 
consisting of a large, heavily glycosilated, 
amino-terminal external domain of 
approximately 400-500 residues, a single 
transmembrane region and a large highly 
conserved carboxy-terminal cytoplasmic 
domain of 707 residues (106, 107) 
(Fig.2.9.). CD45 is structurally hetero-
genous. The different molecular weight 
isoforms are ranging from approx. 180 kDa 
to 220 kDa and are expressed in cell-type 
specific patterns. The B lymphocytes 
express the highest MW form of 220 kDa, 
thymocytes express predominantly the 
lowest MW form of 180 kDa, and different 
subsets of T cells express multiple MW 
forms (107). The structural heterogeneity of CD45 was found to be the result of 
differences in the primary structure of the external domain. Six isoforms of the molecule 
were identified by sequencing mouse, rat and human cDNAs (107). These isoforms are 
generated by the alternative splicing of exons 4- 6 (also termed exons A, B and C) each 
encoding approx. 50 amino acids inserted near the amino terminus of the molecule (108, 
109). The sequences encoded by the alternaltively-spliced exons are rich in serine and 
threonine residues and contain multiple potential sites for O-linked oligosaccharides. 
There is direct biochemical evidence that these regions of the molecule are modified by 
extensive O-linked glycosylation (110). In addition, it has been shown that human CD45 
C i t o p l a s m 
Fig. 2.9. Structure of CD45. CD45 consits of a variable 
extracellular domain that contains N- and O- linked 
glycosilation sites, a transmembrane region and an 
intracellular part that contains the two phosphatase 
domains. The regions encoded by the alternatively spliced 
exons A B and C are shown. 
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A variety of anti-CD45 monoclonal antibodies (MAbs) that selectively react with 
different MW forms of CD45 glycoprotein bind to antigenic determinants localized to one 
or more of the segments encoded by the alternatively-spliced exons (112). These MAbs 
are designated as CD45R (restricted) antibodies with CD45RA, CD45RB and CD45RC 
Mabs reacting with CD45 isoforms containing the segments encoded by exons 4, 5 and 6, 
respectively. In human, a CD45R0 MAb, UCHL-1, has been obtained that recognizes only 
the smallest CD45 isoform. CD45R MAbs have been useful in distinguishing between 
different subpopulations of functional T cells (113, 114). The human T cells can be divided 
into two subpopulations -naive and memory T cells- based upon their expression of CD45 
RA or CD45R0 isoforms (113). 
Unlike the extracellular region, the transmembrane region and the intracellular 
707-residue C-terminal part of CD45 are identical in all isoforms. 
The cytoplasmic domain of CD45 consits of a membrane proximal region, 
followed by two PTPase domains of approximately 240 residues separated by a short 
spacer region, and a carboxy-terminal tail (106). The second (membrane distal) PTPase 
domain appears to be catalytically inactive. CD45 mutants containing the PTPase I domain 
but not the PTPase II domain have been shown to have less than 14% activity as 
compared to the wild type CD45 implying that the activity of PTPase domain I was not 
independent upon domain II (115). Whether the second PTPase domain plays a regulatory 
role or is required to maintain the active conformation of domain I is unclear. 
2.2.3.8.2. The role of CD45 in TCR signaling 
CD45 plays an important role in signal transduction and T lymphocyte activation. 
CD45-deficient lymphocytes are greatly diminished in their capacity to respond to antigen 
or to receptor cross-linking (116). Many physiological effects of various anti-CD45 MAbs 
including stimulation of IL-2 production (117), cell-mediated cytotoxicity (118), 
neutrophyl migration (119) arid the stimulation of proliferative responses (117, 120) have 
been described. CD 45 activity was found to be increased up to 10 times during mitosis 
both in a pre-B lymphoma and in cytolytic T lymphocyte lines suggesting that CD45 has a 
role in phosphorylation events during cell division (121). T cells lacking CD45 fail to 
respond to stimulation by antigen or mitogenic antibodies (116, 122) and responsiveness is 
restored on introducing CD45 into the cells by transfection (123). The requirement for 
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CD45 in T cell activation seems to reside at a very early stage in the signal transduction 
cascade, since, in the absence of CD45, the rapid receptor-triggered tyrosine 
phosphorylation of cellular proteins is severely reduced (124), resulting in impaired 
activation of PLCy (125) and disturbed Ca2+ homeostasis (107, 124). It was suggested 
that CD45 regulates these events is by regulating the Src-family PTKs p56fc* and P596"1 
(54, 56, 126, 127 and see also chapter 3.2.1.). In CD45-deficient T cells, carboxy-terminal 
tyrosine phosphorylation of p56/cfc and p59^n is increased, resulting in a decrease in their 
kinase activities (reviewed in ref. 54). As both p56te* and p59'r>", have been implicated in 
signal transduction through the TCR, the inability to activate these enzymes is likely to 
result in antigen receptor unresponsiveness (128). 
Whether CD45 functions to regulate other aspects of activation is unknown. 
However, CD45 was shown to interact strongly and specifically with phosphorylated TCR 
C, chain and to dephosphorylate it (129). Therefore, CD45 may also function in either 
maintaining the C, chain in a dephosphorylated form, or in dephosphorylating C, chain after 
cellular activation. 
2.2.3.8.3. The role of CD45 isoforms in the regulation of TCR signaling 
Convincing evidence that different CD45 isoforms vary in their ability to promote 
TCR signalling has come from studies in which different CD45 isoforms were expressed in 
a murine thymoma cell line co-transfected with CD4 and a clonotypic TCR (130). 
Comparison of the isoform-specific subclones revealed that MHC-peptide-TCR 
interactions induced IL-2 secretion in the order CD45R0> CD45RC> CD45RABC = 
CD45RBC. Differences in biological responsiveness occurred in the absence of consistent 
differences in either total tyrosine phosphorylation or Src family PTK activity, suggesting 
that CD45 may have other substrates than the Src family PTKs. 
Furthermore, CD45R0 was found to preferentially co-distribute with the 
TCR/CD4 when compared with CD45RABC (131). The ability to co-cap with CD4-TCR 
maps to CD45 ectodomain (131). These results suggest that the expression of distinct 
CD45 isoforms play a key role in modulating TCR responsiveness to antigenic stimulation. 
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3. AIMS OF THE STUDY 
Despite the extensive investigation, there are still two main controversial topics 
regarding the ¿¡ chain signalling- one concerning the mechanism that leads to the 
generation of the differently phosphorylated forms of the TCR C chain, the other one 
regarding to the significance of the presence of three functional units (ITAMs) in the 
cytoplasmic tail of the ¿¡ chain. 
In order to get new data about the mechanism that contributes to the generation of 
the differently phosphorylated forms of the TCR ¿¡ chain we tried to answer the following 
questions: 
1. Which ITAMs and individual tyrosine residues in the human £ chain can be 
phosphorylated in vitro by Lck and Fyn protein tyrosine kinases? 
2. Does the CD45 PTPase have a role in the formation of the ¿¡ chain phosphorylation 
pattern? 
Our second aim was to determine whether the three ITAMs within the ¿¡ chain are 
functionally equivalent or they are required to activate distinct signalling pathways. For 
this purpose we tried to answer the following questions: 
1. Which procedure for cell permeabilization is suitable for studying early signalling 
events such as tyrosine phosphorylation? 
2. What is the effect of the various mono- and bi-phosphorylated ¿¡ITAM peptides on 
tyrosine phosphorylation of cellular proteins? 
3. What can be the enzymatic components (e.g. PTKs and/or PTPs) involved in the 
triggering of T cells by IT AM phosphopeptides? 
4. Does the phospho-ITAM peptides modulate the adaptor-protein mediated 
interactions? 
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4. Materials and Methods 
4.1. Cells and antibodies. 
The human T cell lines, Jurkat, J6 and HPB-ALL were cultured in RPMI 1640 
(GIBCO) tissue culture medium supplemented with 5% heat inactivated FCS (Gen-Inter). 
The JCaM 1.6., a p561ck negative variant of Jurkat, was cultured in RPMI supplemented 
with 10% heat inactivated FCS. Human peripheral blood mononuclear cells (PBMC) were 
obtained from healthy donors by density gradient centrifugation over Ficoll-Hypaque. 
Polyclonal antisera were generated by injecting rabbits with branched multiple antigenic 
peptides (MAPs) of the p56lck (aminoacids 39-64), pSg^ (aminoacids 20-48) and the 
ZAP-70 (aminoacids 485-499) sequences (140). Immunoglobulin fractions of the antisera 
were purified by MAbTrap G according to the manufacturer's instructions (Pharmacia, 
Uppsala, Sweden). Anti-phosphotyrosine monoclonal antibody 4G10 was purchased from 
Upstate Biotechnology. Monoclonal antibodies recognizing CD45, GB3 (103) and T2/53 
reactive with CD43, were developed in our laboratory (141, 142). Rabbit immunoglobulin 
to mouse immunoglobulins (RaMIg) and RaMIg coupled to horseradish peroxidase 
(HRPO) were purchased from DAKO. 
4.2. Synthesis of C oligopeptides. 
The nonphosphorylated peptide substrates (Table 5.1.) were synthesized by solid 
phase technique utilizing tBoc chemistry. The peptides were purified by semipreparative 
reverse phase HPLC and were characterized by amino acid composition and mass 
spectrometry. The purity of the peptides was above 97% as determined by HPLC. 
The phosphorylated peptides (Table 2.) were prepared using Fmoc (106) 
technique. The phosphate moiety was incorporated with di-tert. butyl-N,N' diethyl 
phosphoramidite method as described previously (144, 145). The isolation and 
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characterization were carried out as described for nonphosphorylated peptides except that 
an additional capillary zone electrophoresis step was included. 
4.3. Cell permeabilization 
Cells were harvested by centrifugation, washed in RPMI without supplements, 
resuspended in RPMI and incubated for 5 min. at 37°. In order to find a rapid and efficient 
permeabilizing agent, the following permeabilization procedures were applied: 
a) Streptolysin O permeabilisation. Streptolysin O (Sigma) permeabilization was 
performed according to the protocol described by Spiller and Tidd (146). Cells 
( l x l 0 7 / s a m p l e ) were washed once in permeabilization buffer (Ca2+-Mg2+ free PBS 
supplemented with lOmM DTT), resuspended in 1ml permeabilization buffer containing 
0.5-2001.U/ml of streptolysin O (Sigma) and incubated at 37°C for 5 to 30. minutes. 
b) Digitonin permeabilization (159). Cells (2xl07) were incubated for 5 min at 37°C in 
lml PBS containing 2mM EGTA, 2mM MgCl2, 2% BSA and 10-50 pg digitonin (136). 
c) L-a-lysophosphatidyl choline permeabilization (136, 137, 149). Different human 
leukaemic cell lines were pelleted, washed once with RPMI, resuspended at 4xl07/ml in 
ice-cold permeabilization buffer (see ref. 70 and Appendix) and incubated further on ice 
for 5 min in a cold room. Permeabilization was initiated by adding 1/10 vol. of ice cold 
LPC stock containing 10- 3000 pg/ml LPC and cells were further incubated on ice for 1 
min. Alternatively, all the above mentioned steps were carried out at room temperature or 
at 37° C. 
Permeability was assessed using trypan blue exclusion in each case. 
4.4. Cell stimulation and anti-phosphotyrosine blotting.(134) 
Stimulation of intact or permeable cells (4xl07/ml) was initiated by adding either 
anti-CD3 mAb, UCHT1 (lOpg/ml) (kindly provided by Dr. P.C.L. Beverly) or 500pM 
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IT AM peptides. Cells were further incubated for 2 min at 37°C and activation was 
stopped with 2x concentrated ice-cold lysis buffer (see Appendix). The cells were 
incubated on ice for 30 min and nuclear/cytoskeletal components were removed by 
centrifiigation at 12,000xg for 15 min. Cell lysates from 2xlOscells were diluted with 3x 
concentrated reducing Laemmli sample buffer (see Appendix.) and samples were boiled 
for 5 min before SDS-PAGE analysis. Proteins and prestained molecular weight markers 
(GIBCO-BRL) were separated on 10% SDS-PAGE, then transferred to nitrocellulose 
membranes (Schleicher & Schuell) using 20% methanol containing transfer buffer (see 
Appendix). The membranes were blocked using Tris-buffered saline (TBS) (see 
Appendix), containing 3% cold fish gelatine (Sigma) for 1 h at room temperature and 
subsequently probed with 4G10 anti-phosphotyrosine monoclonal antibody (Upstate 
Biotechnology Inc.) diluted 1:10,000 in gelatine-TBS for 1 h at 4°C. Membranes were 
then washed three times with TBS containing 0.05% Tween -20, and incubated further for 
lh at 4°C with rabbit anti-mouse IgG conjugated to horseradish peroxidasel: 7500 
(DAKO), and washed again. Immunoreactive proteins were visualized by enhanced 
chemiluminescence (ECL) detection system (Amersham). 
4.5. Kinase immunoprecipitation and peptide phosphorylation assay 
(136.145) 
For immunoprecipitation of kinases, postnuclear supernatants from nonstimulated 
or peptide-stimulated Jurkat T cells (lxl07/sample) were mixed with antibody-coupled 
agarose beads (10 pl/sample) and incubated for lh at 4°C. The immunoprecipitates were 
washed once in kinase lysis buffer and twice in kinase assay buffer (see Appendix). The 
enzyme reaction was performed in 20pl kinase assay buffer (see Appendix) containing 
lpCi of [y-32P]ATP and 15 nmol oligopeptide substrate for 20 minutes at 37°C and was 
stopped by cooling the samples to 4°C. The phosphorylated peptides were separated in a 
40% alkaline polyacrylamide gel (147). The gel was dried and analyzed by 
phosphoimager. 
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4.6. Detection of the ITAM-induced kinase phosphorylation in 
permeabilized T cells 
Permeabilized Jurkat T cells (lxl07/sample) were stimulated for 3 min at 37°C 
with 500pM ¿¡-ITAM peptides or anti CD3 mAb in the presence of lOpCi [y-32P]ATP or 
left unstimulated. Cell lysis and immunoprecipitations were performed as described above 
(see sections 4.4 and 4.5). Immunoprecipitated kinases and were eluted from beads using 
10 pi of 2x concentrated Laemmli sample buffer and analysed using 10% SDS-PAGE gel. 
In order to hydrolyse the radioactive phosphate groups from phospho-serine and phospho-
threonine residues, the gels were incubated in ÍM KOH at 55°C for lh, then dried and 
analyzed by using phospho-imager (Molecular Dynamics 445 SI). 
4.7. Purification of Grb-2 associated proteins 
After being stimulatd or left untreated, lx 107 J6 T cells were lysed in ice cold lysis 
buffer for 15 min on ice. After centrifugádon the supernatants were mixed with 5pg of 
GST-Grb fusion protein coupled to glutathione beads (kindly provided by Dr László 
Buday, SOTE Institute of Biochemistry, Budapest) and incubated for lh at 4°C. The 
precipitates were washed three times with lysis buffer (see Appendix) and boiled for 5 min 
in Laemmli sample buffer The electrophoresis and immunobloting of affinity purified 
proteins were performed as described in section 4.4. 
4.8. Immunoprecipitation of CD45 and phosphatase assay.(134.146) 
HPB-ALL cells (107 cells/sample) were lysed for lh in ice cold phosphatase lysis 
buffer (see Appendix) supplemented with 1 Opg/ml aprotinin and ImM PMSF. Postnuclear 
supernatants were mixed with lOpl protein G-coupled Sepharose beads (Pharmacia) 
precoated with 20 pg affinity purified anti CD45 mAb and incubated for lh at 4°C. The 
immunoprecipitates were washed twice in phosphatase lysis buffer and once in 
phosphatase assay buffer (see Appendix). The beads were incubated in lOpl phosphatase 
assay buffer supplemented with ImM DTT and 2.5 nmols phosphopeptide for lh at 37°C. 




Ng et. al. (148). Brifely, the supernatants of the reaction mixtures (10 pi) were transferred 
into the wells of a 96 well microtiter plate (Falcon), mixed with 90 pi of malachite green 
reagent and incubated further for 15 minutes at room temperature for colour development. 
Absorbance was determined at 650nm wavelength using an EIA plate reader. For each 
peptide background absorbance was evaluated using a control sample 
Fig.4.1. Standard curve for the evaluation of inorganic phosphate concentration using 
malachite green reagent. The standard curve for inorganic phosphate detection was obtained using 
potassium dihydrogen phosphate (KH2P04) over a range of concentration between 0 and 10 nmol. 
which contained 10 pi phosphatase assay buffer supplemented with ImM DTT, 2.5 
nmols phosphopeptide and 90 pi malachite green reagent. The absorbance of the control 
was substracted from sample absorbance. The value obtained after substraction was used 
to determine the release of inorganic phosphate from a standard curve for inorganic 
phosphate detection (Fig. 4.1). 
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5. Results 
5.1. The role of PTKs and CD45 in the generation of different 
phospho-C forms 
5.1.1 All the tyrosine residues within the ITAMs of the TCR C, chain 
are phosphorylated by Src kinases 
The TCR Q chain is phosphorylated on multiple tyrosine residues upon T cell 
stimulation and Src family tyrosine kinases, p56/ti; and p59^" have been implicated in this 
process (135). To compare the specificity of different kinases in the phosphorylation of 
particular tyrosines of the C, chain we have carried out in vitro phosphorylation 
experiments using immunoprecipitated enzymes as the source of kinase activity and 
substrates representing different parts of the C, chain. Table 5.1. shows the aminoacid 
sequence of C, chain and the oligopeptides used in this study: 1. synthetic IT AM 
fragments (underlined), 2. one-tyrosine residue containing short oligopeptides (printed 
with blank characters). 
Table S.l. A. The aminoacid sequence of the C, chain intracellular part and the localization of the 
oligopeptide substrates. The three ITAMs are underlined and marked as (¡(1), C{2), ¿¡(3). The seven 
synthetic oligopeptides representing the individual tyrosines using blank characters and marked as <¡(0), 
C(l)a, £(l)b, £(2)a, £(2)b, £(3)a, £(3)b. B. The position of the oligopeptide substrates within the C, chain is 
shown. 
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First, we investigated the phosphorylation of the oligopeptides corresponding to 
the ITAMs of the £ chain. All ITAM-s (£(1), £(2), £(3)) were phosphorylated by the 
immunoprecipitates of p56lck and p59lvn (Fig.5.1.A) as compared to the controls, ZAP 70 
and rabbit anti-mouse immunoglobulins (RaMIg) (Fig.5.1.B.). Similar patterns of 
phosphorylation of the ITAMs were obtained when immunoprecipitates of p56lck and 
p59hn were used as kinase source (Fig.5.1. A). The £(1) ITAM was poorly 
phosphorylated by both p56lck and p59tyn as compared to the £(2) and £(3). This may be a 
consequence of the solubility problems we encounterd in the case of £(1) peptide. The 
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Fig. 5.1. In vitro phosphorylation of the oligopeptides 
representing the ITAMs of the £ chain by p561ck and 
p59fyn kinases. The phosphorylation of the £(1), £(2) and 
£(3) oligopeptides was analyzed in the presence of 
immunoprecipitated p561ck, p59fyn (A) and ZAP-70 (B) 
kinases. RaMIg coated beads were used for controlling the 
nonspecific background of the kinase reaction (B). The 
phosphorylated peptide substrates were separated in 40% 
alkalic acrylamide gels. 
To determine exactly which tyrosine 
residues of the £ chain were 
phosphorylated by the different 
tyrosine kinases, a panel of short 
oligopeptides containing the individual 
intracellular tyrosines with the 
neighbouring protein sequences were 
used as substrates. As shown in 
Fig.5.2., six of seven oligopeptides 
designated as £(l)a, £(l)b, £(2)a, 
£(2)b, £(3)a and £(3)b (Table 5.1.) 
were phosphorylated by Src family 
member kinases, p56lck and p59fyn, while 
the £(0) control oligopeptide which 
contains a tyrosine residue located 
outside the ITAMs remained 
unphosphorylated. The intensity of the 
phosphorylation obtained by the various enzymes was different, as p56lck gave a much 
stronger signal than p591>n. When the ZAP70 immunoprecipitate was used, none of the 
oligopeptides were phosphorylated. 
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p56lck p59fyn ZAP70 
Fig. 5.2. In vitro phosphorylation of the short £ oligopeptides by p56fck and p59- kinases. The 
phosphorylation of the Q( 1 )a, CO)b, C(2) a, C(2)b, C(3)a, C(3)b and the £0 oligopeptides were analyzed in the 
presence of immunoprecipitaed kinases. The phosphorylated peptide substrates were separated in 40% 
alkalic acrylamide gels. 
5.1.2. CD 45 discriminates between individual phospho tyrosine 
residues of the C, chain ITAMs. 
Differently phosphorylated 
forms of oligopeptides corresponding 
to the £ ITAMs were synthetized and 
used as substrates for CD45. The 
sequence and the designation of the 
phospho-ITAMs are indicated in 
Table 5.2. The C0)ypyp C0)yyp, 
C(2)yPyP and ¿¡(2)yyp peptides were 
the optimal substrates since they 
were completely dephosphorylated 
by CD45 (Fig. 5.3.). 
Table 5.2. Sequence and designation of the synthetic 
phosphopeptide substrates. The designation of the 
phospho-^ ITAMs peptides is indicated in the left panel. 
The six oligopeptides representing individual 
phosphotyrosines of the C, chain are underlined and their 
designation is shown under the sequence. 
icDyv NOL?NELNLGRREEYDVL N l^yp 
Wyy' NOLYNELNLGRREE^ PVL CO yp 
«Dyr NOLTOF.LNLGRREE?DVL 
«2)/y of.glTnelokdkmaeavseio NOyp $ 
QEGLYNELQKDKMAEAYSEJ.Q C42yp dp (¥) i(2)yV OEGLYNELOKDKMAEA^ SEIG 
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37 
The C(2)ypy and C(3)ypyp ITAMs were poorer substrates for CD45 and the Ç(l)ypy, 
C(3)ypy and Ç(3)yyp were the least efficiently dephosphorylated phosphopeptides 
(Fig.5.3.A). Using the short peptides corresponding to half-ITAM sequences we did not 
found significant differences between the degree of dephosphorylation with the exception 
of the CÇ(2)py that was dephosphorylated by the highest degree (Fig.5.3.B.). This finding 
was according to the results obtained with the whole IT AM oligopeptides since CÇ(2)py 
corresponded to the Ç(2) C terminal phosphorylated IT AM. 
A preferential hydrolysis of the C-terminal phosphotyrosine by CD45 has been observed 
in the case of both whole and half IT AM derived phosphopeptides. Moreover, the 
hydrolysis of the N-terminal phosphotyrosine in the ITAMs peptides was enhanced when 
the C-terminal tyrosine was in phosphorylated form (Fig.5.3.A.). Using CD43 
immunoprecipitate in the phosphatase assay as a negative control, no inorganic phosphate 
release was detected (data not shown). The double phosphorylated peptides were 
dephosphorylated better as it was expected from the results obtained with sigle 
phosphorylated peptides. The best example was the Ç(3) peptide, where the N terminal 
phosphopeptide was hardly dephosphorylated (4%) and the C terminal phosphopeptide 
was dephosphorylated by a low rate (21%). In contrast, the double phosphorylated 

















l)ypy 1 )yyp ¡¡(l)ypyp «2)ypy C(2)yyp ;(2)ypyp S(3)ypy « 3 ) y y p «3)ypyp Peptide 
Fig.5.3. In vitro dephosphorylation of the phosphopeptide substrates representing the differently 
phosphorylatcd ITAMs (A) or the individual phosphotyrosinc residues (B) of the C, chain by CD45. 
CD45 immunoprecipitates were used for dephosphory lation of the phosphopeptide substrates listed in 
Table 5.2. The amount of released inorganic phospliate was measured as described under Section 3. The 
mean data and the standard deviation from three independent experiments are presented. Above the bars the 
numerical data represent the released phosphate as the percentage of the starting phospliate content of 
phosphopeptide substrates. 
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5.2.Study on the role of different phosphorvlated forms of the 
C-ITAMs in the induction of the eorlv biochemical events of T- cell 
activation 
One of the earliest biochemical events during T cell activation is the tyrosine 
phosphorylation of the ITAMs in the TCR £ chain and CD3 chains. The pattern of the 
phosphorylation may essentially regulate the outcome of the cell response to the 
extracellular signals. Our aim was to analyze the role of the phosphorylation of the 
individual C phospho-tyrosine residues in the induction of the early signaling events during 
T cell activation. To examine this question we analyzed the effect of synthetic 
oligopeptides representing the differently phosphorylated forms (N- or C-terminal, or both 
tyrosines) of the three C, chain ITAMs on the early signaling events in permeabilized 
lymphocytes. The first step was to establish the proper conditions for permeabilization of 
cells used for intracellular tyrosine phosphorylation studies (136, 137). 
5.2.1. Conditions for permeabilization of cells used for intracellular 
tyrosine phosphorylation 
5.2.1.1.Selection of an optimal reagent for cell permeabilization 
We compared different reagents, namely streptolysin O (SLO), digitonin and L-
a ^phosphatidylcholine (LPC) for their ability to efficiently permeabilize leukaemic T 
cells and/or peripheral blood mononuclear cells (PBMC). 
Streptolysin-0 mediated permeabilization required a high concentration (> 200 
I.U/ml) and long incubation (30 minutes) to fully permeabilize 107 J6 cells or PBMC at 
37°C (Fig. 5.4 ). Permeabilization with digitonin also required 10-30 min and it was not 
well reproducible (136). 
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Fig.5.4 Kinetics and concentration-dependence of cell pcrmcabilization with streptolysin-O (SLO). 
Jurkat T cells (107/ml) were incubated for the indicated time points with different amounts of SLO. Cell 
permeability was assesed using trypan blue exclusion assay. 
The LPC mediated permeabilization has been the most reliable, because it was highly 
reproducible in the case of different types of cells (different leukaemic cell lines, PBMC) 
and the permeabilization was completed in a short time (less than 1 min). The amount of 
LPC, the appropriate time and the optimal temperature required for pemeabilization have 
been established in a serial of experiments. We found that LPC at 50 pig/ml 
permeabilized a wide variety of cell lines at 107-108 cell/ml concentration within 1 min 
(Fig. 5.5.). Permeabilization carried out at 4°C or 37°C was equally efficient (data not 
shown). 
41 
LPC(ng/ml): - — 0 - • - ! - * - 1 0 - * - 2 5 - * - 5 0 -O-lOO 
Fig. 5.5. Kinetics and concentration-dependence of cell permcabilization with lysophosphatidyl 
choline (LPC). Jurkat T cells (4xl07/ml) were incubated for the indicated time points with different 
amounts of LPC. Cell permeability was assesed using trypan blue exclusion assay. 
5.2.1.2. Conditions for low background protein tyrosine 
phosphorylation in permeabilized leukaemic cells 
A common feature of the most frequently used permeabilizing reagents is that 
they induce a significant tyrosine phosphorylation in most of the leukaemic T cell lines, 
which may obscure the regulatory effect of the biomolecules which are tested (Chitu et. 
al. unpublished observation and 70, 72). Therefore, we aimed to establish a 
permeabilization procedure that resolves this problem. 
First, we determined the temperature conditions and the composition of the 
permeabilization buffer that produce a low background protein tyrosine phosphorylation 
and a good signal to noise ratio in LPC permeabilized cells. We found that the 
temperature conditions during permeabilization dramatically influenced the overall 
tyrosine phosphorylation. Cells permeabilized at 37° C gave a high background signal 
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(Fig. 5.6. C. lane 1) while the cells permeabilized on ice showed a much lower basal 
tyrosine phosphorylation (Fig.5.6.B lane 1) (137). 
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Fig. 5.6. Tyrosine phosphorylation induced by TCR in intact and permeabilized cells. Intact J6 cells 
(A) or J6 cells permeabilized with LPC on ice (B) or at 37°C (C) were stimulated with 10 pg/ml UCHT-1 
for 2 min at 37°C (lanes 2) or were left unstimulated (lanes 1). The induction of protein tyrosine 
phosphorylation was analyzed by immunobloting using anti-phosphotyrosine 4G10. 
When the low temperature was not strictly controlled during the permeabilization, 
namely the procedure was not done in a cold room, keeping the samples and reagents on 
ice, the LPC induced tyrosine phosphorylation in unstimulated cells was always observed 
(data not shown). We also assessed whether the induction of the background at higher 
Fig. 5.7. Effect of the elimination of bivalent cations from the permeabilisation buffer on permeabilization-
induced background. A. Non-permeabilized Jurkat T cells, non-stimulated or stimulated with lOpg/ml of anti-
CD3 MAb UCHT-1. B. Cells were permeabilized with LPC for 1 min. at 37°C in 40 mM HEPES supplemented with 
the indicated cations at the concentrations specified in Section 4 (Materials and Methods) and stimulated with 
UCHT-1 or left unstimulated. The induction of protein tyrosine phosphorylation was analyzed by immunoblotting of 
SDS-PAGE fractionated whole cell lysates, with anti-phosphotyrosine Mab, 4G10. 
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temperatures than 4 C can be avoided by elimination of bivalent cations like Ca , Mg" 
and Mn" from the permeabilization buffer. We found that omitting any of the three ions 
from the permeabilizing buffer did not affect either the background or the induced 
phosphorylation when permeabilization was carried out at higher temperature (Fig5.7.). 
"VI J I 
When Mg and Mn" or all three cations were eliminated from the permeabilizing buffer, 
both the background and the TCR-induced tyrosine phosphorylation decreased 
dramatically (137). This result shows that kinase activity requires the presence of either 
Mg2+ or Mn :+ while Ca2+ presence is not obligatory for the activity of tyrosine kinases. 
5.2.1.3 Responsiveness of permeabilized cells to antl TCR stimulation 
We determined whether LPC permeabilized T 
cells were able to respond to TCR stimulation by 
analyzing the TCR induced tyrosine phosphorylation 
and whether this response was comparable to that of 
intact cells. As Figure 5.6. A and B shows, the 
background tyrosine phosphorylation in unstimulated 
cells (lanes 1) and the induced tyrosine 
phosphorylation in TCR activated cells (lanes 2) are 
comparable in intact (panel A) and permeabilized 
(panel B) cells when permeabilization occurred on ice. 
In contrast, permeabilization at 37°C increased the 
tyrosine phosphorylation in non-stimulated cells and 
concealed the anti-TCR induced tyrosine 
phosphorylation (Fig. 5.6. C.) Next we analyzed 
whether the cells, permeabilized in the above-described 
manner, were suitable for studying the tyrosine phosphorylation induced by a membrane 
impermeable synthetic peptide. A biphosphorylated peptide representing the second 
IT AM of the TCR C, subunit (138, 139) and its non-phosphorylated counterpart were 
introduced into LPC permeabilized J6 cells. As the Fig. 5.8. shows, the phosphopeptide 
induced a high degree of phosphorylation (lane 3) compared to the unstimulated cells or 
cells stimulated with non-phosphorylated peptide (lanes 1 and 2 respectively) (137). 
Fig.5.8. Stimulation of tyrosine 
phosphorylation by TCR C, 
peptides in LPC-permeabilized 
J6 cells. Cells, permeabilized with 
LPC were untreated (lanel) or were 
treated with synthetic peptides 
derived from the second ITAM of 
TCR C chain in unphosphorylated 
(lane 2) or biphosphorylated (lane 
3) forms. 
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5.2.2 Effect of differently phosphoryloted forms of the C-ITAMs on 
tyrosine phosphorylation in permeobilized T cells 
5.2.2.1. Differently phosphoryloted¿f-ITAM peptides induce partially 
distinct patterns of tyrosine phosphorylation in permeabilized Jurkat T 
cells. 
Our aim was to determine whether the differently phosphorylated forms of the 
ITAMs found in the TCR ¿¡-chain may trigger qualitatively or quantitatively distinct early 
biochemical events of T- cell activation. For this purpose, a panel of mono-, bi- and non-
phosphorylated oligopeptides corresponding to each ITAM in the (¡-chain (Table 5.2.) 
were introduced into permeabilized Jurkat T cells and the induction of protein tyrosine 
phosphorylation was analyzed by anti-phosphotyrosine blotting. As Fig.5.9.shows, the 
effect of ITAM peptides on the pattern of the tyrosine phosphorylation of intracellular 
substrates was dependent on the primary structure and phosphorylation pattern of the 
phospho-peptides. Permeabilizing buffer alone or the non-phosphorylated peptides had 
essentially no effect (Fig.5.9.). Both qualitative and quantitative differences were 
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Fig. 5.9. Whole-cell protein tyrosine phosphorylation in Jurkat T cells stimulated with anti-CD3 mAb 
or differently phosphorylated ¿¡-ITAM peptides. A. Intact cells were stimulated for 3 min with anti-CD3 
mAb UCHT-1 or left unstimulated. B and C. L-a lysophosphatidylcholine permeabilized cells were 
stimulated for 2 min with either anti-CD3 mAb or (¡-ITAM peptides. Whole-cell lysates were resolved by 
10% SDS-PAGE and immunobloted with anti-phosphotyrosine mAb 4G10. 
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and Table 5.3.). For example, the phosphorylation of proteins with high molecular 
weights (69- 150kDa) was induced only by £( 1 )yyp, C( 1 )yPYP and ¿¡(2)ypyp. Moreover, the 
increase in the phosphorylation of several proteins such as p51-53, p46-48, p42-43 was 
induced by all phospho- ¿¡ITAM peptides except for the N-terminus phosphorylated 
forms although in variable extent. Similarly, the increased phosphorylation of proteins 
with molecular masses 33-35 and 31-32 kDa was induced by all phospho- ¿¡ITAM 
peptides except for the N-terminus phosphorylated forms of the first and third ITAM 
(C(l)ypy and ¿¡(3)ypy, respectively). 
Tyrosine phosphorylation of p29 was induced only by cell stimulation with anti-CD3 
mAb or C(l)yyp, ¿¡(l)ypyp and C(2)ypyp (Table 5.3.). As shown in Fig. 5.9. and in Table 3, 
there are quantitative differences in the ability of phospho-ITAMs to induce tyrosine 
ITAM concentration (fiM) Phosphorylation of intracellular 
proteins. The most potent _ ® <=> ® ® r r 
® JS? « « <=S 
inductors of tyrosine 
phosphorylation were the 
peptides corresponding to the 
biphosphorylated forms of 
ITAM1 and ITAM2 (C(l)ypyp 
and ¿¡(2)ypyp), followed by 
¿¡(l)yyp and ¿¡(3)ypyp In contrast, 
C(l)ypy and ¿¡(3)ypy showed the 
poorest capacity to induce 
tyrosine phosphorylation of 
intracellular proteins. Similar 
patterns of tyrosine 
phosphorylation were found 
when PBMC were used (not 
shown). Effective induction of 
protein phosphorylation was 
dependent on cellular architecture, since addition of ¿¡(2)ypyp (one of the most potent 
2 9 -
Fig. 5.10. Dose-dependence of TCR C(2)ypyp ITAM-
induced tyrosine phosphorylation. Permeabilized J6 cells 
were stimulated for 3 min with different concentrations of 
C(2)yV peptide as indicated. The induction of protein 
tyrosine phosphorylation was analyzed by SDS-PAGE of 
whole cell lysates followed by imunoblotting with anti-
phosphotyrosine mAb, 4G10. 
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inductor of tyrosine phosphorylation) following cell lysis did not induce any response 
(Fig5.9.). 
The phospho-ITAM stimulation was time and concentration dependent. Protein 
tyrosine phosphorylation was detected using ¿¡(2)ypyp peptide at a concentration higher 
than 100 pM (Fig5.10 ). The requirement for such a high concentration of peptide was 
consistent with the reported binding affinities (nM-pM) of biphosphorylated ITAMs for 
the SH2 domains of ZAP-70 (70). Another reason for the requirement of this high 
concentration of peptides might be that the phospho-ITAM peptides were not protected 
and therefore they could be rapidly dephosphorylated by intracellular protein tyrosine 
phosphatases. Under these conditions, only a small portion of phospho-ITAM peptide 
may reach its site of action. 
Induction of protein tyrosine 
phosphorylation occurred as fast 
as 15 sec following stimulation, 
and maximal phosphorylation was 
observed between 1 and 5 min 
(Fig. 5.11.). High dose (500pM) 
of non-phosphorylated C, peptides, 
used as controls, did not induce 
tyrosine phosphorylation of 
intracellular substrates within 3 
min of stimulation (Fig. 5.9.), 
indicating that the tyrosine 
residues were not phosphorylated 
in permeabilized cells (Fig.5.9). 
Therefore, the data obtained using 
single phosphorylated or non-
phosphorylated peptides reflect 
the function of the particular peptide and do not show the function of a peptide modified 
by the cellular signal transduction machinery. 
0 15" 30 " 4 5 " 1' 3' 5' 10' 
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Fig. 5.11. Kinetics of C(2)ypyp ITAM (500 pM)- induced 
protein tyrosine phosphorylation. Permeabilized J6 cells were 
stimulated with 500 pM ¿¡(2)ypyp peptide for the indicated time 
points. Detergent-soluble proteins were separated by 10% SDS-
PAGE, followed by immunoblotting with antiphosphotyrosine 
mAb. The numbers on the left indicate the migration of 
molecular weight markers in kilodaltons. 
47 
5.2.2.2. Analysis of the role of different tyrosine kinases in the 
ITAM-induced tyrosine phosphorylation 
In order to determine the role of p56lck and ZAP-70 - two tyrosine kinases 
essential for T cell activation- in the induction of tyrosine phosphorylation by phospho-
¿¡ITAMs, we compared the effect of ¿¡-ITAM peptides in Jurkat T line, the p56lck 
deficient JCaM 1.6. and the PI 16 Syk/ZAP deficient Jurkat variants. As shown in 
Figure5.12. and Table 5.3. the pattern of phospho- IT AM induced tyrosine phospho-
proteins in J CaM 1.6 cells was partially different from that of Jurkat T cells. In JCaM1.6. 
cells the ¿¡(l)ITAM peptides did not induce phosphorylation of proteins with molecular 
mass of 140-150 and 103-107 kDa and the phosphorylation of proteins with molecular 
mass 78-80, 61-63, 56-57 and 51-53 kDa was much weaker compared to that of Jurkat. In 
the case of ¿¡(2) phospho-peptides, the N-terminus phosphorylated form of the ITAM2 
peptide, ¿¡2ypy was unable to induce tyrosine phosphorylation in JCaM 1.6. 
The peptide corresponding to 
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Fig. 5.12. Whole cell protein tyrosine phosphorylation in 
JCaM 1.6. T cells stimulated with phosphorylated and 
non-phosphorylated -ITAM peptides. Permeabilzed cells 
were either left unstimulated or were stimulated for 3 min 
with 500 pM peptides corresponding to the different 
phospho-forms of TCR ¿¡-chain ITAMs. Whole cell lysates 
were resolved by SDS-PAGE and immunoblotted with anti-
phosphotyrosine mAb 4G10. The migration of molecular 
weiaht markers is indicated at the left in kDa. 
the C-terminus phosphorylated 
form of the ¿¡(2) failed to 
induce tyrosine phosphoryla-
tion of proteins with molecular 
mass of 61-63, 56-57, 35-37 
and 31-33 kDa, in JCaM 1.6. as 
compared to Jurkat cells (Table 
5.3.). The tyrosine phospho-
proteins of molecular mass 61-
63, 56-57, 33-35 and 31-33 
kDa were induced by ¿¡(2)ypy 
only in Jurkat. Moreover, the 
stimulation of Jurkat but not 
JCam 1.6. cells with the 
C(2)ypyp peptide resulted in the 
phosphorylation of proteins 
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with molecular masses of 140-150 and 103-107 kDa. The effect of monophosphorylated 
£(3) peptides seemed to be totally dependent on p56/ci activity, since they did not induce 
any signal in JCaM 1.6. The stimulation of JCaM 1.6. T cells with biphosphorylated £(3) 
peptide (£(3)ypyp) resulted in phosphorylation of a single band with a relative molecular 
mass of 46-48 kDa. 
In order to establish the contribution of Syk family kinases in the induction of 
tyrosine phosphorylation by phospho-ITAM peptides, we used PI 16 cells - a recently 
characterized Syk/ZAP deficient variant of Jurkat (96). As previously reported by 
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Fig. 5.13. Whole cell protein tyrosine phosphorylation in PI 16 cells stimulated with phosphorylated 
and non-phosphorylated £-ITAM peptides. Permeabilized cells were either left unstimulated or 
stimulated for 3 min with 10pg/ml anti CD3 mAb OKT3 or with 500 pM ¿¡-peptides. Whole cell lysates 
were resolved by SDS-Page and immunobloted with anti-phosphotyrosim\ne mAb 4G10. The migration 
of molecular weiaht markers is indicated on the left in kilodaltons. 
Williams et al., (96) PI 16 cells showed no consistent increase in protein tyrosine 
phosphorylation in response to anti CD3 antibodies (Fig. 5.13 lanes none and OKT3), 
while in wild type Jurkat T cells TCR stimulation triggered rapid increase in tyrosine 
phosphorylation of several proteins (Fig. 5 .9. and Table 5.3.). The first and second ITAM 
peptides, when biphosphorylated, induced a reasonable tyrosine phosphorylation in PI 16 
cells (Fig. 5.13 and Table 5.3.). 
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Table 5.3. Qualitative and quantitative differences in the effect of differentially phosphorylated 
ITAM peptides on intracellular protein tyrosine phosphorylation in permcabilizcd T cell lines (wild 
type Jurkat and the p56/c*-negative JCaM 1.6. and ZAP/Syk negative PI 16 Jurkat variants). The 
table contains the evaluation of tyrosine phosphorylated bands that reproducibly appeared in two or three 
independent experiments. Empty cells indicate the absence of the band, shadowed cells indicate increased 
phosphorylation as compared to the nonstimulated control; ND: not determined. 
Possible identity 













R l k 
She 
Rlk 





78-80 69-71 61-63 56-57 51-53 46-48 42-43 35-37 31-33 29-30 
Nonstimulated 
control 
Jurkat +/- +/- + +/- +/- +/-
JCam 
P116 2+ 2+ 
Anti-CD3 
Jurkat 1 4 + +/- + 4r + 4 
JCam N D 
P116 3+ 3+ 
Non-phospho-
rylated ITAM 
Jurkat +/- +/- +/- + +/- +/- +/-
JCam 
P116 2+ 2+ 
C ( i ) / y 
Jurkat + +/- . . 4 : •; +/- +/- +/-
JCam 
P116 2+ 2+ 
« 1 ) 5 - / 
Jurkat + +/- 4 4 4+ 4+ 4+ 3+ 24- 2+ 2+ - ' 4-.: 
JCam +/- 4 ' + iiijü; + • + 2+ 24- 24 2 4 
P116 + 2+ 2+ - + :: 4-
«t)yV 
Jurkat 2+ + + 2+ 4+ 4+ 4+ 3+ 24- 3 + 4 4 4 
JCam 2+ 2+ 2+ 2+ 2+ 2+ 3+ 3+ 4 
P116 4 2 + + 3+ 3+ •+ + 
;(2)y"y 
Jurkat 2+ 3+ +/- 4 
JCam 
P116 4• / . 3+ 34-
?(2)yy" 
Jurkat 2+ - 3 + +/- +/-
JCam +/- :+/- +/• 
P116 3+ 3+ 
Jurkat 3+ 3+ 2+ 3+ 4+ 4+ 4+ 3+ 3+ 3+ 34 4 
JCam 3+ 3+ 3+ 3+ 3+ 3+ 3+ 3+ 34 4 
P116 + ' + 2+ + 3+ 34- " :4- + 
?(3)/y 
Jurkat +/- + +/- + 4- / - +/-
JCam 
P116 + 2+ 2 4 -
C(3)y/ 
Jurkat + + 2+ 4- ' 1 initfcii:! 4 
JCam 
P116 2+ 2 4 -
£(?)yV 
Jurkat 2+ 2+ 2+ 2+ 4 2+ 2 4 
JCam 2+ 
P116 4 + ; 3+' 34- i 4/-
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However, the intensity of ITAM-induced phosphorylation was lower in PI 16 compared 
to Jurkat and, tyrosine phosphorylation of proteins with molecular mass of 150, 69-71 
and 51-53 kDa could not be induced in PI 16. 
5.2.2.3. Phospho-ITAM peptides induce phosphorylation of p56lck and 
ZAP-70protein tyrosine kinases. 
The earliest steps in TCR-mediated signal transduction are the phosphorylation 
and activation of Src and Syk family tyrosine kinases. To determine whether these events 
were triggered by phosphorylated £ ITAMs, phospho-ITAM peptides were introduced 
into permeabilized Jurkat cells in the presence of y32P-ATP and kinase phosphorylation 
was assessed. 
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Fig.5.14. Incorporation of 32P into p56/c* (A) and ZAP-70 (B) after stimulation of Jurkat T cells with 
(-ITAM phosphopcptides. Permeabilized Jurkat T cells were left unstimulated (none) or stimulated either 
with 500 pM of Q peptide or with 10 pg/ml anti CD3 mAb UCHT-1 in tlie presence of [y-32P] ATP as 
described under section Materials and Methods. The increase in phosphorylation upon stimulation is 
expressed as the ratio between 32P incorporated in p56 , a and ZAP kinases after stimulation and the amount 
of 32P incorporated without stimulation. 
Fig. 5.14. shows the changes in Lck and ZAP-70 phosphorylation induced by different ¿¡ 
IT AM peptides. The effect of phospho-ITAM peptides on tyrosine phosphorylation of 
Lck (Fig.5.14. A) and ZAP-70 (Fig. 5.14. B) was dependent on the primary structure and 
phosphorylation pattern of the phospho-peptides. The phosphorylated ¿¡-ITAM peptides 
51 
displayed the following hierarchy of increasing Lck phosphorylation: 
£(2)yV»C(2)yyp>C(3)yY>C(3)yyp> £(l)ypyp>£(l)yyp>C(2)ypy >£(3)ypy>£(l)ypy. For 
ZAP phosphorylation the hierarchy was different: £(2)ypyp>£( 1 )ypyp> 
£(l)yyp>£(3)ypy >£(2)yyp>C(2)ypy>£(3)yyp>£(3)ypyp= £(l)ypy. 
5.2.2.4. Protein tyrosine phosphatase inhibitor, PAO modifies the 
phosphorylation pattern of intracellular proteins induced by £-ITAM 
phosphopeptides. 
In order to determine the contribution of protein tyrosine phosphatases (PTPs) to 
the tyrosine phosphorylation induced by the £-ITAM phosphopeptides, we performed 
experiments where permeabilized T cells were stimulated with peptides in the presence or 
absence of a PTP inhibitor, phenylarsine oxide (PAO). As Fig.5.15. shows, £-ITAM 
phosphopeptides induced a stronger tyrosine phosphorylation in Jurkat T cells in the 
absence of 15mM PAO as they did in the presence of PAO. Treatment of permeabilized 
cells with PAO alone induced phosphorylation of proteins of molecular masses 63, 56, 
46, 42 and 29 kDa as compared to the untreated cells (Fig.5.15). Phosphopeptide -
induced phosphorylation of proteins with molecular masses of 150, 120, 102 and 75 kDa 
was completely inhibited, while peptide-induced phosphorylation of proteins with 
molecular masses of 46, 43, 36, 30 and 29 kDa was essentially not affected by PAO (Fig 
5.15 and Table 5.4.). The peptide-induced phosphorylation of proteins with molecular 
masses 63, 56, 53, 34 and 28 kDa was decreased in the presence of PAO. 
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Fig. 5.15. Effect of phenylarsine oxide (PAO) on ¿¡-ITAM induced tyrosine phosphorylation in 
Jurkat T cells. Permeabilized Jurkat T cells were left unstimulated (none) or were stimulated for 3 min 
with 500 pM phospho-ITAM peptide in the presence (PAO+) or the absence (PAO-) of 15 mM PAO. 
Tyrosine phosphoproteins from whole cell lysates were detected by anti-phosphotyrosine blotting. The 
migration of molecular weight markers is indicated on the left in kilodaltons. 
Table 5.4. Effect of tyrosine phosphatase inhibitor PAO on the ¿¡-ITAM peptides induced protein 
tyrosine phosphorylation in Jurkat T cells. Empty cells indicate the absence of the band, shadowed cells 
indicate increased phosphorylation as compared to the nonstimulated control. 
Possible identity 








t u b u l i n 
R l k 
She 
Rlk She LAT ? » 9 




PAO- +/- +/- +/- +/- +/- + +/-
PAO+ + + + + + + 
« D y y p 
PAO- ++ ++ ++ ++ +++ ++ ++ ++ 4-H- ++ + ++ ++ + 
PAO+ + + + ++ ++ ++ +/- + ++ +/-
C C D y V 
PAO- +++ +++ +++ +++ +++ +++ +++ + - H - ++ +++ +++ ++ 
PAO+ - H - + ++ ++ +++ +++ + +++ +++ + 
C ( 2 ) y V 
PAO- +++ +++ +++ +++ +++ +++ - K + +++ ++ +++ +++ ++ 
PAO+ ++ + ++ ++ +++ +++ + +++ +++ + 
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5.2.3. ¿¡-ITAM1 and ¿¡-ITAM2 but not ¿¡-ITAM3 phosphopeptides induce 
association of Grb-2 with tyrosine phosphorylated proteins 
In order to determine whether phospho-^ peptides regulate T cell response only 
by modulating tyrosine phosphorylation or by affecting adaptor protein mediated 
molecular interactions as well, we examined the changes in the pattern of growth factor 
receptor binding protein 2 (Grb-2) associated phosphoproteins in £ peptide stimulated T 
cells. Grb 2 is an adaptor protein which ensures the link between TCR and Ras activation 
pathway. 
We have used GST-Grb2 fusion protein to affinity purify proteins that associate 
with Grb-2 from lysates prepared from non-stimulated or phospho-peptide stimulated J6 
T cells. The data on Figure.5.16.show that the Grb-2 fusion protein precipitates multiple 
proteins that are tyrosine phosphorylated in peptide-stimulated cells. 
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Fig. 5.16. Analysis of the association of tyrosine posphorylated proteins isolated from ITAM-stimulated 
T cells with GST-Grb-2 fusion protein. J6 cells were stimulated with anti-CD3 mAb UCHT-1 or with the 
indicated ¿¡-ITAM peptides. Cellular proteins were precipitated using either glutathione-agarose beads (A) 
or glutathione-agarose beads preloaded with GST-Grb2 fusion protein (B). Affinity-purified proteins were 
subjected to 10% SDS-PAGE and analyzed by immunobloting with the anti-phosphotyrosine mAb 4G10. 
The migration of the molecular mass standards is indicated to the left in kilodaltons. 
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The pattern of peptide-induced associations is different depending on the primary 
structure and the phosphorylation site of the peptides. Biphosphorylated £(1)ITAM 
peptide (£(l)ypyp) induced Grb-2 association with tyrosine phosphoproteins of 127, 113, 
52, 46, 36 and 27 kDa and increased Grb-2 association with proteins of 85, 71 and 55 
kDa as compared to the non-stimulated control. Biphosphorylated £(2) (£(2)ypyp) induced 
the association of Grb-2 with identical proteins as £(l)ypyp did and with three additional 
proteins with molecular mass of 175, 153 and 20 kDa. The N-terminus phosphorylated 
£(2)ITAM (£(2)ypy) induced only a single new association with p36. In contrast, 
biphosphorylated £(3)ITAM (£(3)ypyp) as well as the nonphosphorylated £(3)ITAM 
(£(3)) peptides did not induce neither new association nor the increase in Grb-2 
association with the constitutively associated proteins. 
5.3. Phospho-C ITAM peptides induce tyrosine phosphorylation in B cells 
The well documented 
structural and functional 
conservation of the ITAMs in 
lypmhocyte signalling, prom-
pted us to determine the 
effect of £-ITAM phospho-
peptides on tyrosine phospho-
rylation in B cells. As Fig. 
5.17. shows, different £ chain 
ITAMs are able to induce 
distinct patterns of tyrosine 
phosphorylation in B cells. 
Similarly to T cells, the effect 
of ITAMs was dependent on their primary structure and the site of phosphorylation. The 
£(2)ypyp peptide was the most potent inductor of tyrosine phosphorylation both in T and 
B cells. However, unlike T cells where £(1) peptides £(l)yyp and £(l)ypyp were very 
cx & ex 
Fig. 5.17. Effect of £-ITSAM peptides in B cell line BL-41. 
Cells were stimulated for 3 min with 500 pM £-ITAM peptides or 
left unstimulated. Whole cell lysates were resolved by SDS-
PAGE and immunobloted with antiphosphotyrosine mAb 4G10. 
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effective in stimulation of tyrosine phosphorylation, in B cells these peptides were much 
less active. Furthermore, the C(3) peptides C(3)ypy and C(3)/yp that were almost inactive 
in T cells, were very efficient in inducing tyrosine phosphorylation in B cells. 
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6. Discussion 
6.1. Src-family PTKs and CD45 act together in the generation of 
TCR C chain phosphorylation 
Phosphorylation of multiple tyrosine residues within the £ polypeptide is crucial 
for the recruitment of effector molecules into the TCR complex. Differently 
phosphorylated forms of the £ chain subunit can be found in T cells at distinct 
differentiation stages or activated under different conditions (150). The different £ IT AM 
sequences may be responsible for connecting the TCR to various effector pathways. 
Several important signalling and adaptor proteins, such as ZAP70, She, Grb2, pStf*" and 
the p85 subunit of PI3K bind to the phosphorylated TCR IT AM sequences via their SH2 
domains in vitro (83, 153, 154) on a sequence and phosphorylation dependent fashion 
(68-74). Therefore, the composition of the signalling complex formed on the internal face 
of the TCR may depend on the phosphorylation pattern of the £ and CD3 chains and may 
regulate the eventual cell response. However, the mechanism of formation of the distinct 
phosphorylation patterns and the contribution of the kinases and phosphatases to this 
process have not been yet revealed. Therefore, first we have investigated the 
phosphorylation of a substrate panel derived from the human £ chain in the presence of 
different Src family kinases. 
Our results showed that the Src kinases, p56/ck and pSSft", that have been 
implicated in TCR signalling (135), phosphorylated the £ chain-related oligopeptides. A 
higher intensity of overall phosphorylation was detected using p56te* compared to p59^"\ 
These results were consistent with previous findings that under physiological conditions 
p56/ck likely represented the relevant kinase acting in £ chain phosphorylation (151). 
However, it can not be excluded that the detected difference was due to the distinct 
affinity of the antibodies used for the isolation of the enzymes. The experiments 
concerning the phosphorylation of the seven individual tyrosines located in the 
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intracellular part of the human Q chain, showed that six of them were phosphorylated by 
Src family tyrosine kinases p56/c* and p596"', but not by ZAP-70. All tyrosine residues 
susceptible to phosphorylation were located in the functionally important conserved 
ITAMs. The non-conserved, membrane proximal tyrosine was not phosphorylated by 
either src or syk kinases or by cell free extract prepared from HPB-ALL cells (138), 
suggesting that this tyrosine did not have a phosphorylation dependent function. The 
patterns of the peptide phosphorylation generated by different Src kinases, including 
those which were irrelevant in TCR signalling (138), such as p59ly" and p60irc were 
similar. Similarity in the patterns meant that the various Src kinases did not show 
different specificity toward the peptides. These results suggested that the Src kinases 
were not at all or might not be the only components regulating the generation of different 
phosphorylation patterns in the C, chain. 
The phosphorylation stage of the proteins is determined by the balance between 
the kinases and phosphatases. The main tyrosine phosphatase that may control the 
phosphorylation pattern of the C, chain is CD45. Therefore we have examined the role of, 
CD45, in this process. The results showed that each ITAMs phosphorylated on the N-
terminal tyrosine were poorer substrates for CD45 compared to the identical peptide 
phosphorylated on C-terminal tyrosine residues. It was observed that the 
dephosphorylation of the C-terminal phosphotyrosine in ¿¡(1) and ¿¡(2) ITAMs was 
complete, independently of the phosphorylation state of the N-terminal tyrosine residue. 
In contrast, the hydrolysis of the N-terminal phosphotyrosine in these peptides was 
enhanced when the C-terminal tyrosine was in phosphorylated form. When doubly 
phosphorylated peptides of any ITAMs were used as substrates, the amount of released Pi 
was greater than the sum of Pi released from the N- and C-terminal monophosphorylated 
peptides. This suggested that the interaction of CD45 with one of the phosphotyrosine 
residues increased its activity toward the second phospho-tyrosine. Substrate binding may 
alter catalytic activity and/or affinity of CD45 PTPase domain 1 or may induce the 
cryptic PTPase activity of domain 2. Although, the ¿¡(3) phospho-peptides were the 
weakest substrates, the dephosphorylation efficiency of both the C and N-terminal 
tyrosine was dramatically influenced by the phosphorylation state of the neighbouring 
tyrosine residue. 
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Despite the observation that CD45 showed a preference toward the C terminal 
phospho-tyrosines in either the short or the full length IT AM peptides, there was a much 
less pronounced difference in the dephosphorylation rate of the different short 
phosphopeptides compared to the whole IT AM sequences. A possible explanation for this 
may be that the short peptides did not have the proper conformation and/or did not 
contain aminoacids important for the substrate specificity. This hypothesis was supported 
by data published previously by Zhang et al. (152) which showed that the Yersinia 
PTPase and rat PTP-1 substrate specificity for EGF receptor derived phosphopeptides 
was primarily dictated by residues located to the N-terminal side of the phosphotyrosine 
residue. 
The ability of CD45 to discriminate between the different ITAM-derived 
phosphopeptides suggests that CD45 may play a role in formation of a functional pattern 
of the phosphorylated C chain. 
We suggest that the Src family kinases and the CD45 tyrosine phosphatase act 
together in controlling the C chain phosphorylation. The ability of the CD45 to 
distinguish between the various tyrosine residues may play an essential role in the 
formation of a functional phosphorylation pattern of the C, chain. The in vivo contribution 
of the Src PTKs and CD45 in generation different phosphorylation forms of the TCR C 
chain should be the subject of future investigations. 
6.2. L-a lysophosphatidyl choline permeabilized cells are suitable 
tools for intracellular tyrosine phosphorylation studies 
Permeabilized cells are widely applied for studying the effect of membrane 
impermeant biomolecules on signalling pathways. After permeabilization with reagents 
commonly used for this purpose, the architecture of the cells remains essentially intact and 
hence they retain their ability.to respond to cell surface receptor stimulation as far as early 
cellular responses are concerned. Early signalling events, such as tyrosine and serine 
phosphorylation of cellular proteins (70, 72, 149), generation of cAMP (156) or inositol-
phosphate hydrolysis (157, 158) can be investigated after the stimulation of permeabilized 
cells. However, a common feature of most of the permeabilizing reagents is that they 
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induce significant tyrosine phosphorylation in most of the leukaemic cell lines, which may 
obscure the regulatory effect of the biomolecules which are tested (70, 72, 137). We 
selected L-a ^phosphatidylcholine as permeabilizing reagent, because it effectively 
permeabilized many types of cells within 1 min and generated pore size that allowed 
molecules as large as 150 kDa to enter the cells (137). The results show that the well-
controlled, low temperature during permeabilization is a key factor for successful usage of 
permeabilized cells for signal transduction studies. Furthermore, the procedure described 
by us allows a fast and efficient permeabilization of a variety of leukaemic cell lines 
without affecting the responsiveness of the cells to external stimuli (137). 
6.3. Different C-ITAMs play distinct role in early biochemical 
events of T- cell activation 
The presence of multiple of ITAMs within the £ chain raises the question whether 
the individual ITAMs and their differently phosphorylated forms may function as docking 
regions for distinct effector molecules in order to activate distinct signalling pathways or it 
may simply provide a mechanism for signal amplification. To answer this question, we 
analyzed the effect of synthetic oligopeptides representing the differently phosphorylated 
forms (N-, C-terminal, or both tyrosines) of the three £ chain ITAMs on the early 
signalling events in permeabilized leukaemic T cells. 
Our findings showed that synthetic phosphopeptides representing the differently 
phosphorylated forms of the £-ITAMs were capable of inducing protein tyrosine 
phosphorylation of partially distinct sets of substrates, when introduced into T cells. 
Effective induction of protein phosphorylation was dependent on cellular architecture, 
since addition of £(2)ypyp (one of the most potent inductor of tyrosine phosphorylation) 
following cell lysis did not induce any response. The phospho-ITAMs had different 
abilities to enhance tyrosine phosphorylation of Lck and ZAP-70 kinases in Jurkat T 
cells. Since the activity of these kinases is controlled by tyrosine phosphorylation (54, 
88), one possible explanation for the ITAM-induced increase in tyrosine phosphorylation 
of intracellular substrates is the modulation of the activity of these kinases. Further 
evidence that the phospho-ITAM induced increase in tyrosine phosphorylation was 
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mediated at least partially by tyrosine kinases involved in TCR signalling comes from the 
experiments using Jurkat variants, deficient in kinases. When the kinase deficient cell 
lines were stimulated with phospho-ITAM peptides different patterns of tyrosine 
phosphorylation were found as compared to Jurkat. As it is summarised in Table 6.1., 
kinase requirements for induction of phosphorylation by the different forms of the C, 
ITAMs are considerably different. All N-terminal phosphorylated ITAMs (¿¡(l^y, 
C(2)ypy and C(3)ypy) and the C-terminal phosphorylated ITAM 3 (C(3)yyp) need the 
presence of Lck and C0)yPy a nd C(3)yyP phosphopeptides demanded for active ZAP, as 
well. In contrast, function of C(3)ypy peptide was not affected by the absence of ZAP. 
The effect of biphosphorylated ITAM peptides and of C(l)yyp was dependent on the 
presence of enzymatically active Lck or Syk/ZAP kinases in a variable extent. Some 
peptides failed to induce the phosphorylation of specific proteins, for example the 
proteins with molecular masses of 140-150 and 103-107 kDa could not be induced by 
C(2)yPyP in JCaM while phosphorylation of other substrates was unaffected. 
Table 6.1. Requirement for Lck and ZAP/SYk PTKs for phospho -ITAMs induced tyrosine 
phosphorylation. The evaluation was done by comparing the pattern and the intensity of peptide-induced 
tyrosine phosphorylation of cell proteins in wild-type Jurkat and kinase deficient cell lines, PI 16 and JCaM 
1.6. „yes": absolutely required, „mostly" indicates that in kinase deficient cells only the increased 
phosphorylation of constitutively phosphorylated bands was observed, „partial" indicates differences in the 
pattern of tyrosine phosphorylation, ,,no"-not required. 
PTK 
Requirement for PTK for phospho -ITAMs induced tyrosine phosphorylation 
C i D / y C(l)yyp C(l)ypyp C(2)ypy C(2)yyp C t t W C(3)ypy C(3)yyp C(3)yV 
p56,c* 
yes partial partial yes partial partial yes yes most 
ZAP/Syk 
yes partial partial most most partial no yes partial 
Recent data have demonstrated a functional role for Lck beyond ITAM phosphorylation 
and the activation of ZAP-70 and Syk PTKs (61, 62). The expression of constitutively 
active Syk or Zap-70 family PTKs in the p561ck-deficient JCaM 1.6 cells failed to rescue 
signalling events downstream of tyrosine phosphorylation, demonstrating a functional 
role for Lck beyond the activation of ZAP and Syk (61). Additionally, phosphorylation of 
61 
She, a downstream signalling component in TCR activation is synergisticly 
phosphorylated by Syk and Lck (62). These data may explain the differences that we 
found both in the pattern of induced tyrosine phosphoproteins and the decreased intensity 
of phosphorylation of several intracellular proteins when phospho-ITAM peptides were 
introduced into JCaM 1.6., (Lck deficient cells) and in wild type Jurkat T cells. A good 
example is the decrease in the phosphorylation of the 51-53 kDa molecular mass protein 
in JCaM induced by the (¡(1) peptides compared to Jurkat. This 51-53 kDa band may 
represent tyrosine phosphorylated She, that is a substrate for both Syk and Lck (62). 
The induction of tyrosine phosphorylated bands in the absence of p56fcfc may be 
attributed to the alternative activation of p59^" and/or Syk/ZAP, or other, unidentified 
tyrosine kinases, or to the involvement of tyrosine phosphatases. Gene targeting in mice 
has revealed that p59^" can partially substitute for Lck in TCR signalling (53, see also 
section 2.2.3.1.). Furthermore, unlike ZAP-70, Syk may be activated by direct binding of 
phosphorylated ITAMs and it does not require the phosphorylation by Lck to become 
fully activated (41, 88). Further evidence for the involvement of Syk-family kinases in 
CITAM-induced tyrosine phosphorylation comes from experiments where Syk/ZAP 
deficient Jurkat variant PI 16 was stimulated with phospho-^ peptides. In the absence of 
active Syk-family kinases, the overall peptide-induced tyrosine phosphorylation of 
cellular proteins was weaker as compared to wild type Jurkat. Significantly, the 
phosphorylation of several proteins such as the one with molecular mass of 150 kDa, 
could not be induced neither in JCaM 1.6. nor in PI 16 cells. The molecular weight of this 
protein coincided with that of PLGy that is known a major substrate for Syk and ZAP 
(92). Moreover, Williams and co-workers demonstrated that both Lck and Syk or ZAP-70 
kinases are required for TCR-induced tyrosine phosphorylation of PLCy (98). 
Recent data show that beside the activation of Src and Syk family tyrosine kinases, TCR 
engagement results also in the activation of three members of the Tec family tyrosine 
kinases: EMT/Itk (inducible T cell kinase), Tec and Rlk/Txk (44, 161-163). Tec family 
members are SH2 domain containing proteins and they have been suggested to function 
downstream of Src family kinases (163). Therefore, we cannot rule out. the possibility 
that other tyrosine kinase(s) than the Src and Syk family kinases can mediate the 
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induction of tyrosine phosphorylation by phospho-ITAMs both in wild-type Jurkat and 
kinase-deficient Jurkat variants PI 16 and JCaM 1.6. 
The phosphorylation status of intracellular proteins is determined by the concerted 
function of kinases and phosphatases. Contribution of tyrosine phosphatases to the £-
peptides induced phosphorylation pattern was determined using a protein tyrosine 
phosphatase inhibitor, PAO. Although the pattern of peptide-induced phosphorylation in 
the presence or absence of PAO was similar, yet the relative intensity of tyrosine 
phosphorylation decreased in the presence of PAO. The latter finding indicated a 
contribution of phosphatase(s) to this process. The use of PAO at 15 mM, was previously 
reported to abrogate the activity of CD45 PTP-ase in Jurkat T cells (143). Since a known 
role of CD45 is to activate p56lck and p59fyn PTKs by dephosphorylating their negative 
regulatory site, the reduction in the tyrosine phosphorylation of certain bands observed in 
cells stimulated with phospho-ITAM peptides in the presence of PAO might be due to a 
decreased activity of Src family tyrosine kinases. 
The main consequence of the TCR-induced tyrosine phosphorylation is the 
initiation of downstream signalling cascade by promoting phosphotyrosine-mediated 
protein-protein interactions. Following T cell stimulation, Grb-2 adaptor protein is 
associated with phosphorylated signalling proteins via its SH2 domain and hence 
activating the Ras/MAP kinase pathway. Using biphosphorylated ITAM peptides the 
following results were obtained: the £(1) and £(2) but not the £(3) phosphopeptides 
induce association between Grb-2 and tyrosine phosphorylated proteins. The pattern of 
Grb-2 associated phosphoproteins was different when £(1) ITAM or £(2) ITAM peptides 
were used. Hence, the three £-ITAMs differ not only in the induction of tyrosine 
phosphorylation but also in their capacity to couple TCR to downstream Grb-2 mediated 
signalling pathways. 
6.4. TCR C chain ITAM phosphopeptides induce different patterns 
of tyrosine phosphorylation in B and T cell lines 
Signal transduction following ligation of TCR or BCR is mediated by common 
families of intracellular enzymes and signalling molecules and by conserved sequences 
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involved in protein-protein interaction (ITAM and proline-rich motifs, SH2 and SH3 
domains) (164). These similarities prompted us to determine whether the £ chain ITAMs 
are functional only in T cells or they may induce tyrosine phosphorylation events in B 
cells as well. Similarly to T cells, the peptides corresponding to the differently 
phosphorylated IT AM sequences from the £ chain increased tyrosine phosphorylation of 
cellular proteins in B cells in a primary structure and phosphorylation pattern-dependent 
manner. However, we found significant differences between the ability of the first and 
third £ IT AM phosphopeptides to induce tyrosine phosphorylation in B cells as compared 
to T cells. These differences may result from phosphopeptide interaction with distinct 
sets of SH2 domains containing proteins that are selectively expressed in B cells such as 
the members of Src family tyrosine kinases Blk and Lyn and the Tec family tyrosine 
kinase Btk (53, 164). 
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7. Concluding Remarks 
Multiple signaling pathways can be initiated by activation of the TCR. The TCR 
must provide a mechanism(s) by which the activation machinery is driven into one or the 
other pathway. The generation of various phosphorylated forms of the C, chain is most 
likely one of those mechanisms. The sequence of events at the C, chain is probably co-
ordinated through various levels of regulation. One level of regulation would be the 
control of the generation of various phosphorylated forms of the C, chain. This may be 
mediated through the temporal activation of specific kinases (63) and/or the balance 
between kinase(s) and phosphatase(s) activities (138). Another level of control would be 
the binding of distinct signalling proteins at distinct IT AM sequences that may allow for 
multiple, well controlled signalling pathways to be activated through the TCR complex 
(68-74). Our data indicate that the three ¿¡-ITAMs differ in their capacity to induce 
tyrosine phosphorylation of intracellular proteins and of individual tyrosine kinases 
(p56,c* and ZAP-70) in permeabilized T cells, according to their phosphorylation site and 
their primary sequence. The first and second IT AM sequences of the C, chain may have 
similar but not totally overlapping functions. This conclusion results from their similar 
but not identical abilities to induce tyrosine phosphorylation and association of Grb-2 
with intracellular phosphoproteins. In contrast, the third ITAM may have distinct 
functions since the peptides corresponding to its different phospho-forms shows the 
poorest capacity to induce tyrosine phosphorylation events and they are unable to induce 
either new association or the increase in the amount of Grb-2 associated phosphoproteins. 
We also found that from a panel of peptides representing the mono- and biphosphorylated 
forms of the three ITAM sequences present in the C, chain, the phospho-peptides 
corresponding to the third ITAM were the weakest substrates for CD45 in vitro (138, see 
also section 5.1.). These findings suggest that ¿¡(3) ITAM have a special function in TCR 
signalling which may be reflected by its poor dephosphorylation by CD45 and by its 
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weak ability to induce tyrosine phosphorylation and association of cellular proteins with 
Grb-2. Other investigations also have suggested that the C terminal IT AM (¿¡(3)) may be 
unique among the TCR ITAMs. It shows the poorest capacity to bind to ZAP and Syk 
(153), however it exerts a preferential binding to the actin cytoskeleton (160). It was also 
indicated, that the most significant change from a-helix to (3-sheet conformation occurs 
in the ¿¡(3) IT AM upon phosphorylation (139). 
Taken toghether, our findings support the idea that the role of the three ITAMs 
from the C, chain is to activate multiple signalling pathways through the TCR complex. 




^ All the tryrosine residues located in TCR £ chain ITAM sequences are 
substrates for Src family kinases Lck and Fyn suggesting that the Src kinases may not be 
the only components regulating the generation of different phosphorylation patterns in 
the £ chain. 
^ CD45 PTPase can discriminate between individulal phospho tyrosine residues 
of the £ chain ITAMs indicating that CD45 may be involved in the formation of the 
multiple phosphorylated forms of £ chain. 
^ Cells permeabilized with L-a lysophosphatidyl choline under strictly 
controlled temperature conditions are suitable tools for intracellular tyrosine 
phosphorylation studies. 
^ Differently phosphorylated forms of the £-ITAMs are capable of inducing 
protein-tyrosine phosphorylation of distinct substrate sets, when introduced into 
permeabilized T cells. The p56,c* and ZAP-70/Syk PTKs were involved in phospho-
ITAMs induced tyrosine phosphorylation, as it has been shown in enzyme deficient cells. 
^ The three £-ITAMs and their various phosphorylated forms differ in their 
capacity to couple TCR to downstream adaptor protein mediated signalling pathways. 
^ T h e first and second ITAM sequences of the £ chain may have similar but not 
totally overlapping functions in TCR signalling. In contrast, the third ITAM may have 
distinct functions since the peptides corresponding to its different phospho-forms shows 
67 
the poorest capacity to induce tyrosine phosphorylation in T cells and they are unable to 
induce changes in Grb-2 association with cellular phosphoproteins. 
^ There are differences between the ability of the C IT AM phosphopeptides to 
induce tyrosine phosphorylation in B cells as compared to T cells. These differences may 
result from phosphopeptide interaction with distinct sets of SH2 domains containing 
proteins that are selectively expressed in B cells such as the members of Src family 
tyrosine kinases Blk and Lyn and the Tec family tyrosine kinase Btk. 
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Ap-l: activating protein 1 
APC: antigen presenting cell 
ATP: adenosine triphosphate 
BCR: B-cell antigen receptor 
BSA: bovine serum albumin 
CD: cluster of differentiation 
CDR: complementarity-determining regions 
Csk: C-terminal Src kinase 
CTLA-4: cytotoxic T lymphocyte antigen 4 
DTT: dithiotreithol 
ECL: enhanced chemiluminiscence 
EDTA: ethylenediaminetetraacetic acid 
EGTA: ethylnglycol-bis-N, N, N' ,N'-tetraacetic acid 
ERK: extracellular signal-regulated kinase 
FcR: Fc receptors 
FCS: fetal calf serum 
GAP: Ras GTP-ase activating protein 
GEF: guanine nucleotide exchange factor 
Grb-2: growth factor receptor binding protein 2 
GST: Glutathione-S transferase 
GTP: guanosine triphosphate 
HPLC: high pressure liquid chromatography 
HRPO: horseradish peroxidase 
Ig: immunoglobulin 
IL-2: interleukin 2 
IT AM: Immunoreceptor Tyrosine-based Activation Motif 
LAT: linker for activation of T cells 
LPC: L-a lysophospatidyl choline 
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MAbs: monoclonal antibodies 
MAP: multiple antigenic peptide 
MAPK: mitogen activated kinase 
MAPKK: MAPK kinase 
MAPKKK: MAPK kinase kinase 
MHC: major histocompatibility complex 
MLC: myosin light chain 
NEPHGE: non-equilibrium pH-gradient gel electrophoresis 
NFAT: nuclear factor of activated T cells 
NFkB: nuclear factor kB 
PAGE: polyacrylamide gel electrophoresis 
PAK: p21-activated kinse 
PAO: phenylarsine oxide 
PBMC: peripheral blood mononuclear cells 
PBS: phosphate buffered saline 
PI3K: phosphatidylinositol 3-kinase 
PIP5K: phosphatidylinositol 4-phosphate 5-kinase 
PLC y: phospholipase Cy 
PMSF: phenylmethhylsulfonyl fluoride 
PTK: protein tyrosine kinase 
PTP: protein tyrosine phosphatase 
RaMIg: rabbit immunoglobulin to mouse immunoglobulins 
SDS: sodium dodecyl sulfate 
SH: Src homology domain 
SHP: SH2 domain containing protein tyrosine phosphatase 
SLO: streptolysin O 
SLP-76: SH2 domain-containing leukocyte phosphoprotein of 76 kDa 
TCR: T-cell antigen receptor 
TmC: transmembrane charge 
WASP: CDC-42 associated Wiscott Aldrich syndrome protein 
ZAP-70: zeta associated protein of 70 kDa 
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13. Summary in English 
The mechanisms of ITAM-mediated signal transduction have been extensively 
studied. It is well documented that differently phosphorylated forms of the £ subunit can 
be found in T cells at distinct differentiation stages or activated under different 
conditions. However the cellular components that participates in the development of the 
differently phosphorylated forms of the TCR £ chain have not been identified and the 
exact role of the presence of multiple ITAMs in TCR is not well documented. 
Our aim was to study the following main questions: 
1. What is the contribution of Src family tyrosine kinases and CD45 protein tyrosine 
phosphatase to the generation of the differently phosphorylated forms of the TCR £ 
chain? 
2. Are the three ITAMs within £ chain required to activate distinct signalling patways or 
they are functionally redundant? 
The results obtained in this work are as follows: 
1. The £ chain ITAMs and individual tyrosine residues except the non-conserved 
membrane proximal one were phosphorylated by p56lck and p59fyn CD45 
discriminated between the individual phosphotyrosine residues of the £ chain ITAMs. 
These findings suggested that CD45 may be involved in the regulation of the 
phosphorylation pattern of the £ chain. 
2. Cell permeabilization with L-a lysophosphatidylcholine was established and was 
proven to be efficient and reproducible and did not affect the cell responsiveness to 
anti-TCR stimulation. 
3. Different £ITAMs phosphorylated at distinct sites induced phosphorylation of 
partially distinct substrate sets in Jurkat T cells 
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4. Kinase requirements for induction of phosphorylation by the different forms of the Ç 
ITAMs were considerably different. Effect of certain ITAMs was totally dependent 
on the presence of enzymatically active Lck or Syk/ZAP kinases and other's effect 
depended on these kinases in a variable extent. 
5. Contribution of tyrosine phosphatases to the Ç-peptides-induced phosphorylation 
pattern was determined using a protein tyrosine phosphatase inhibitor. 
6. Phospho-ITAMs regulated the association of specific proteins with the adaptor 
protein, Grb2. 
The two main conclusion drawn from this study are: 
1. Kinases of Src family and CD45 tyrosine phosphatase may act together on the 
formation of the Ç chain phosphorylation pattern. 
2. The individual ITAMs and their differently phosphorylated forms play partially 
distinct role in T cell activation and contribute to signal diversification. 
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14. Magyar nyelvű összefoglaló 
A T sejt receptor C, alegységének ITAM motívumai által közvetített jelátviteli 
utakról nagyszámú tanulmány jelent már meg. A C, láncnak különböző mintázatban 
foszforilált formái vannak jelen az egyes differenciálódási stádiumokban és a különböző 
feltételek mellett aktivált sejtekben. Nem ismert azonban, hogy mi az egyes ITAM 
motívumok pontos szerepe, valamint hogy mely molekulák vesznek részt a különbözően 
foszforilált formák kialakításában. 
A munkánk során a következő kérdésekre kerestük a választ: 
1. Hozzájárulnak-e a Src kinázok és a CD45 protein tirozin foszfatáz a különbözően 
foszforilált formák-létrehozásához? 
2. A C lánc három ITAM szekvenciája különböző szignál transzdukciós utakat indít-e el? 
Eredményeink: 
1. A ( lánc ITAM motívumokat és az egyedi tirozin aminosavakat a p56,ck és p59fzn 
kinázok foszforilálják, a nem konzervált membrán proximális tirozin kivételével. A C, lánc 
ITAM motívumainak egyes foszfo-tirozinjait a CD45 különböző affinitással 
defoszforilálja, s ez arra utal, hogy a CD45 szerepet játszhat a C, lánc foszforilációs 
mintázatának kialakításában. 
2. A sejtmembrán L-a-lizofoszfatidilkolinnal történő permeabilizálására új, hatékony és 
megbízható módszert dolgoztunk ki, ami nem befolyásoltja a sejtek anti-TCR stimulusra 
adott válaszképességét. 
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3. A £ lánc egyes ITAM motívumainak különbözően foszforilált formái a Jurkat T 
sejtekben részben eltérő molekulák foszforilálódását indukálták. 
4. A £ lánc különböző ITAM motívumai által indukált foszforilációhoz eltérő kinázok 
szükségesek. Egyes ITAM szekvenciák hatása teljes mértékben, míg másoké különböző 
mértékben függ az Lek illetve Syk/ZAP kinázok enzimaktivitásától. 
5. Protein tirozin foszfatáz inhibitor segítségével meghatároztuk a tirozin foszfatázok 
részvételét a £ lánc ITAM motívumok által indukált foszforilációs mintázatban. 
6. A foszforilált ITAM motívumok szabályozzák a Grb2 adaptor fehérje szignálfehéijékkel 
való asszociációját. 
Következtetések: 
1. A Src kinázok és a CD45 protein tirozin foszfatáz együttesen alakítják ki a £ lánc 
foszforilációs mintázatát. 
2. Az egyes ITAM szekvenciák és azok különbözően foszforilált formái eltérő szerepet 
játszanak a T sejt aktivációban és különböző jelátviteli utak megindításához járulnak 
hozzá. 














40mM HEPES pH 7.4 
lx LYSIS BUFFER (anti-PY blotting) 
50mM HEPES pH 7.4 




lOmM Na pyrophosphate 
2mM EGTA 
ImM PMSF, lpg/ml each of aprotinin and leupeptin- should be added just before 
2x Laemmli sample buffer 
125 mMTrisCl 
20% glycerol 
4.1 % SDS 
2% 2-ME or 3.1 % DTT 
0.001% Bromphenol Blue 
10% SDS-PAGE gel 
Stacking gel: 5% acrylamide 
0.1% bis-acrylamide 
0.125 M Tris-HCl pH 6.8 
0.1% SDS 
0.086% TEMED (N,N,N\N'-tetramethylethylendiamine) 
0.043% ammonium persulfate 
Resolving gel: 10% acrylamide 
0.266% bis-acrylamide 
0.375 M Tris-HCl pH 6.8 
0.1% SDS 
0.066% TEMED (N.N.N'.N'-tetramethylethylendiamine) 
0.033% ammonium persulfate 
SDS-PAGE Running Buffer 
25 mM Tris 
192 mM glycine 
0.1% SDS 
Western Blot Transfer Buffer 
25 mM Tris 
192 mM Glycine 
20% methanol 
Kinase lysis buffer 
50 mM HEPES pH 7.4 
150mM NaCI 
20mMNaF 
200mM Na orthovanadate 
1% Triton X-100 
ImM PMSF, lpg/ml each of aprotinin and leupeptin- should be added just before 
Kinase assay buffer. 




lOOpM Na orthovanadate 
40% alkaline Polyacrylamide gel 
Stacking gel: 3.3% acrylamide 
0.16% bis-acrylamide 
0.125 MTris-HCl pH 6.8 
0.05% TEMED (N,N,N',N'-tetramethylethylendiamine) 
6M urea 
0.1% ammonium persulfate 
Resolving gel: 40% acrylamide 
0.037% bis-acrylamide 
0.75 MTris-HCl pH 8.8 
0.035% TEMED (N,N,N\N'-tetramethylethylendiamine) 
0.1% ammonium persulfate 
Peptide running buffer: 
0.05 M Tris base 
0.4 M glycine 
Peptide sample buffer: 
250 mM Tris pH 6.8 
12 M urea 
0.001% Bromphenol Blue 
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Phosphatase lysis buffer* 
1% Triton X-100 
20mM Tris pH 7.5 
150mM NaCl 
l.OmMEDTA 
ImMPMSF and lOpg/ml aprotinin- should be added just before use 
Phosphatase assay buffer* 
50 mM Hepes pH 7.0 
KCl lOOmM 
0.1% Triton X-100 
ImMEDTA 
Malachite green reagent* 
Solution I: 0.135% malachite green oxalat 
Solution 2: 4.2% ammonium molibdate in 4M HCl 
Malachite green reagent: lpart solution 1 
1 part solution 2 
2 parts tridistilled water 
0.01% Tween 20 
*All reagents and buffers used in the phosphatase assay must be high purity to 
prevent sample contamination with phosphate. 
